trinitrobenzenesulfonic acid and Bowel Diseases, Inflammatory

trinitrobenzenesulfonic acid has been researched along with Bowel Diseases, Inflammatory in 280 studies

Research

Studies (280)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (0.36)	18.7374
1990's	33 (11.79)	18.2507
2000's	70 (25.00)	29.6817
2010's	137 (48.93)	24.3611
2020's	39 (13.93)	2.80

Authors

Authors	Studies
Abdel-Aziz, H; Efferth, T; Khayyal, MT; Scherner, O; Wadie, W	1
Chen, M; Chen, Z; Li, X; Mao, R; Miao, X; Qiu, C; Ren, J; Wang, P; Yin, T; You, Y; Zheng, R; Zhou, H	1
Ben-Khemis, M; Boudiaf, K; Chevreux, G; Dang, PM; El-Benna, J; Leger, T; Liu, D; Marie, JC; Pelletier, AL; Pintard, C; Song, Z; Terrier, S	1
Chen, J; Liu, C; Liu, YJ; Lv, X; Qi, L; Wang, X; Wu, J; Zhu, S	1
Burukoğlu Dönmez, D; Can, B; Kanbak, G; Özkoç, M; Şentürk, H	1
Mateus, V; Pinto, R; Silva, I; Solas, J	1
Deng, C; Hu, J; Hu, T; Long, Y; Ma, X; Shen, Y; Wu, W; Zeng, Y; Zhao, Y	1
Chen, L; Chen, LL; Chen, YP; Chu, KD; Fan, LM; Liu, YJ; Wang, Y; Xu, W; Xu, WH; Zhang, JP; Zhang, YQ	1
Horsnell, W; Katsandegwaza, B; Smith, K	1
Blanc, P; Boutillier, D; Chamaillard, M; Couturier-Maillard, A; Grangette, C; Hrdý, J; Lapadatescu, C; Pot, B; Procházka, J; Ryffel, B	1
Abdollahi, M; Baeeri, M; Ghafour-Broujerdi, E; Gholami, M; Hassani, S; Mousavi, T; Rahimifard, M; Vakhshiteh, F	1
Cui, Y; Hu, D; Huang, T; Kabayama, S; Ochi, Y; Shigeta, M; Watanabe, Y	1
Estarreja, J; Mateus, V; Pinto, R; Silva, I	1
Cao, YN; Liu, KC; Sun, M; Tu, PF; Wang, XX; Zhang, XM; Zhang, Y; Zou, HY	1
Wu, S; Xie, Y; Xiong, H; Xue, G; Zhang, Y; Zhao, Q; Zhao, R; Zhou, N	1
Chen, H; Guo, L; Jiang, H; Kong, N; Li, F; Li, R; Lin, J; Xu, M; Ye, C; Zhang, F; Zhou, F	1
Bartolí, R; Bernal, C; Domènech, E; Garcia, A; Garcia-Jaraquemada, A; Jou-Ollé, E; Llaves, M; Lorén, V; Mañosa, M; Manyé, J; Pertegaz, A; Schiering, K; Suau, R; Vergara, P	1
Im, M; Jang, SE; Jin, H; Kim, HS; Kim, JW; Kim, KJ; Kyung, S	1
Fu, Y; Gu, M; He, Y; Li, R; Lin, S; Pan, Y; Sheng, J; Tao, Y; Wang, J; Wang, Z; Wei, P; Wu, Z; Xie, H; Xu, J; Zhang, C	1
Chen, C; Czapor-Irzabek, H; Fichna, J; Gorniak, A; Karolewicz, B; Krajewska, JB; Owczarek, A; Pietruszka, P; Tomczyk, D	1
Calabresi, MFF; Di Stasi, LC; Mello, FPF; Miranda, JRA; Próspero, AG; Soares, G; Tanimoto, A	1
Jang, SE; Min, SW	1
He, X; Hu, T; Lan, P; Liang, Z; Liu, H; Wang, F; Wu, X; Zheng, X; Zhou, C	1
Batista, ÂG; Bogusz Junior, S; Cazarin, CBB; da Cruz-Höfling, MA; da Silva-Maia, JK; Leal, RF; Maróstica Junior, MR; Soares, ES	1
Chen, Y; Gao, C; Guo, Z; Wang, J; Xiao, J; Zhou, Z	1
He, XW; Hu, T; Lan, P; Liang, ZX; Liu, GH; Liu, HS; Liu, XH; Smith, LC; Wu, XJ; Wu, XR; Zhang, Y; Zheng, XB; Zhou, C	1
Chen, QQ; Chen, Z; Du, HT; Li, Y; Wan, J; Yuan, J	1
Banerjee, S; Djerdjouri, B; Mouzaoui, S	1
Allahverdi, A; Asadi, F; Ebrahimi-Barough, S; Heidari Barchi Nezhad, R; Khajouee Ravari, S; Lotfibakhshaiesh, N; Mirzaei, MR; Mirzahosseini-Pourranjbar, A; Niknia, S; Tashakori, M; Yousefi-Ahmadipour, A	1
Chen, Q; Chen, Y; Guo, Z; He, Q; Xiu, W	1
Bálint, B; Balogh, P; Boros, É; Kellermayer, Z; Maróti, Z; Nagy, I; Prontvai, B; Sarlós, P; Varga, C; Vincze, Á	1
Ding, MX; Ding, Y; Janyaro, H; Shah, MK; Tahir, AH; Vodyanoy, V; Wan, J	1
Appendino, G; Calzado, MA; Collado, JA; García-Martín, A; Minassi, A; Muñoz, E; Palomares, B; Prados, ME; Unciti-Broceta, JD	1
Assohoun, ALW; Boudebbouze, S; Boutillier, D; Cuffaro, B; Desramaut, J; Grangette, C; Hrdý, J; Maguin, E; Salomé-Desnoulez, S; Súkeníková, L; Waligora-Dupriet, AJ	1
Chen, B; Chen, M; Chen, P; Feng, R; He, Y; Li, X; Li, Y; Mao, R; Qiu, Y; Tian, Z; Wang, Y; Zeng, Z; Zhang, S; Zhang, Y; Zhu, L	1
Bauer, M; Chmielowiec-Korzeniowska, A; Fabisiak, A; Fabisiak, N; Fichna, J; Kamysz, E; Kamysz, W; Kordek, R; Tymczyna, L	1
Capas-Peneda, S; Dias-Pereira, P; Duarte-Araújo, M; Esteves-Monteiro, M; Ferreira-Duarte, M; Gonçalves-Monteiro, S; Magro, F; Menezes-Pinto, D; Morato, M; Rodrigues-Pinto, T	1
Chattopadhyay, N; Mehta, P; Mittal, M; Rajender, S; Rajput, S	1
Arab, HH; Eid, AH; Mahmoud, AM; Senousy, MA	1
Allaman, MM; Goettel, JA; Jacobse, J; Li, J; Otipoby, KL; Sampson, ER; Tyagi, RK; Wilson, KT	1
Jiang, Y; Jin, Q; Kuang, Y; Liu, K; Long, D; Qian, K; Wang, S; Yao, H; Yuan, L; Zhao, H	1
Ling-Fen, X; Tian-Chu, H; Yin, B	1
Amamou, A; Aziz, M; Goichon, A; Guérin, C; Marion-Letellier, R; Rouland, M; Savoye, G; Yaker, L	1
Almeida, LM; Dinis, TC; Figueiredo, I; Freitas, V; Pereira, R; Pereira, SR	1
Kaneko, Y; Kato, K; Kojo, Y; Onoue, S; Sato, H; Seto, Y; Suzuki, H; Tsukada, R	1
Chiu, CT; Hung, SW; Kuo, SN; Yang, CY	1
Banskota, S; Bist, G; Gurung, P; Kadayat, TM; Kim, JA; Lee, ES; Shrestha, A; Thapa Magar, TB	1
Appleyard, CB; Chompre, G; Cruz, ML; Gonzalez Torres, MI; Isidro, AA; Isidro, RA; Lopez, A	1
Chen, R; Chen, X; Dong, X; Huang, X; Huang, Z; Jiang, X; Lin, H; Lin, X; Wu, X; Yang, X	1
Hua, Z; Xu, L; Yang, Y; Zhang, M; Zhang, S; Zhou, L; Zou, X	1
Andrews, C; Anver, MR; Baseler, WA; Davies, LC; Durum, SK; Hanson, ML; Hixon, J; Li, W; McLean, MH; Senkevitch, E; Shen, W; Smith, C; Staniszewska, AK; Steidler, L	1
Golomb, B; Griffey, S; Heeney, D; Marco, M; Srisengfa, Y; Yin, X	1
Suolang, Y; Tang, Y; Zhang, Y; Zhao, L; Zhou, D	1
Kuzmanov, A; Kuzmanova, V; Tzaneva, M; Valcheva-Kuzmanova, S	1
Alard, J; Boutillier, D; Breton, J; Grangette, C; Holowacz, S; Kuylle, S; Peucelle, V; Pot, B	1
Li, L; Long, Y; Shen, Y; Xie, Y; Zeng, Y; Zhao, Y	1
Berindan-Neagoe, I; Catana, CS; Cozma, V; Crăciun, EC; Deak, G; Dumitraşcu, DL; Gherman, CM; Magdas, C; Magdaş, VA; Tabaran, FA	1
Cai, Y; Dong, Z; Du, C; Gao, Y; Lai, W; Ma, N; Pan, J; Shen, H; Xie, X; Yang, C; Yang, W; Zhang, R; Zhang, Y; Zhou, J	1
Costero, AM; Ferri, D; Gaviña, P; González-Álvarez, I; González-Álvarez, M; Martínez-Mañez, R; Merino, V; Parra, M; Pérez-Esteve, É; Sancenón, F; Teruel, AH	1
Jiang, N; Ou, R; Shen, Y; Xu, M; Zeng, Y; Zou, L	1
Banskota, S; Bist, G; Gurung, P; Kadayat, TM; Kim, JA; Lee, ES; Magar, TBT; Shrestha, A	1
Choi, EW; Kim, S; Ko, SY; Park, EJ; Seo, MK	1
Babu, T; Betageri, K; Date, AA; Dimitrion, P; Ensign, LM; Gumber, S; Halpert, G; Hanes, J; Huang, X; Kanvinde, P; Musmanno, O; Narayan, J; Ortiz, J; Wiegand, H; Zierden, H	1
Ben Khemis, M; Dang, PM; El-Benna, J; Hurtado-Nedelec, M; Khichane, Y; Letteron, P; Liu, D; Makhezer, N; Marie, JC; Marzaioli, V; Mojallali, M; Pelletier, AL; Pintard, C; Sannier, A; Tlili, A	1
Beck, SE; Chan, GV; Chan, JL; Chung, L; Ding, H; Fan, H; Geis, AL; Gomes, TAM; Housseau, F; Pardoll, DM; Sears, CL; Tam, AJ; Wang, H; Wu, S; Wu, X	1
Bloomfield, SA; Metzger, CE; Narayanan, SA; Zawieja, DC	1
Liu, X; Xu, X; Yu, X; Zhang, X	1
Liu, M; Lu, Y; Wu, L; Xu, J; Yu, P	2
Cao, G; Chen, X; Li, Q; Sang, X; Shan, Q; Zhu, R	1
Lakshmanan, P; Newton, AMJ	1
Biagioli, M; Capobianco, D; Carino, A; Distrutti, E; Fiorucci, C; Fiorucci, S; Marchianò, S; Ricci, P	1
Bai, X; Jia, W; Jin, X; Lin, J; Liu, M; Liu, X; Shi, H; Yang, Y; Zhang, W; Zhang, Z	1
Bochimoto, H; Fukushima, M; Han, KH; Ishihara, Y; Kitamura, N; Kondoh, D; Nagata, R; Sasaki, M; Shimada, K; Tomiyasu, J	1
Du, H; Li, C; Li, S; Lou, X; Ning, L; Xu, G; Zhou, X; Zhu, H	1
Cai, WY; Chen, Y; Li, Q; Li, YJ; Wang, YJ; Weng, XG; Yan, SC; Yang, Q; Zhu, XX	1
Chen, JDZ; Guo, J; Jin, H; Pasricha, T; Shi, Z; Yin, J	1
Crosier, KE; Crosier, PS; Flores, MV; Hall, CJ; Oehlers, SH; Okuda, KS; Sison, JO	1
Alaimo, D; Brenna, O; Damen, R; Dammen, R; Gustafsson, BI; Haugen, M; Kidd, M; Pfragner, R; Svejda, B	1
Cury, DB; Delboni, MA; Miiji, LO; Mizsputen, SJ; Moss, AC; Pereira, E; Schor, N; Versolato, C	1
Annunziata, ML; Bissonnette, M; Chen, Y; Dougherty, U; Du, J; Golan, MA; Hanauer, SB; Huang, Y; Kong, J; Li, YC; Liu, W; Musch, M; Pekow, J; Zheng, C	1
Gaurav, V; Himanshu, R; Suneela, D	1
Altare, F; Arrieta, MC; Atrott, K; Body-Malapel, M; Colombel, JF; Cortot, A; Deknuydt, F; Desreumaux, P; Djouina, M; Esquerre, N; Frey-Wagner, I; Kanneganti, TD; Neut, C; Pineton de Chambrun, G; Rogler, G; Vignal, C	1
Byrav D S, P; Chakrabarti, A; Khanduja, KL; Medhi, B; Prakash, A; Vaiphei, K	1
Cho, KA; Kang, JL; Kim, KH; Oh, SY; Woo, SY	1
Bai, Y; Bi, LH; Lin, YH; Liu, SD; Wang, JD; Xiong, J	1
Cygankiewicz, AI; Fichna, J; Kordek, R; Krajewska, WM; Małecka-Panas, E; Mokrowiecka, A; Sałaga, M; Sobczak, M; Storr, M; Zakrzewski, PK	1
Chen, J; Dong, L; Huang, Z; Jiang, H; Long, S; Wang, Z; Zhang, J	1
Bhinder, G; Dai, C; Jacobson, K; Morampudi, V; Sham, HP; Vallance, BA; Wu, X	1
He, Q; Li, Q; Wang, F; Wang, L	1
Abdallah, DM; Al-Shorbagy, MY; Arab, HH; Nassar, NN	1
Biancone, L; Caprioli, F; Caruso, R; Colantoni, A; Franzè, E; MacDonald, TT; Marafini, I; Monteleone, G; Monteleone, I; Pallone, F; Sarra, M; Sedda, S; Sica, GS; Sileri, P; Stolfi, C; Zorzi, F	1
Chai, B; Fritze, D; Li, JY; Mulholland, M; Zhang, W	1
Huang, Y; Liang, Y; Xu, J; Zheng, C	1
Chai, B; Fritze, D; Li, JY; Mulholland, MW; Zhang, W	1
Bernards, N; Boisgard, R; Dollé, F; Pottier, G; Thézé, B	1
Fichna, J; Jarmuż, A; Jonakowski, M; Lipkowski, AW; Pilarczyk, A; Sałaga, M; Sobczak, M	1
Basra, S; Brasier, AR; Costinean, S; Croce, CM; Larson, SA; Merwat, S; Verne, GN; Zhou, Q	1
Bakirtzi, K; Fiocchi, C; Iliopoulos, D; Law, IK; Pothoulakis, C; West, G	1
Devisscher, L; Filtjens, J; Kerre, T; Leclercq, G; Plum, J; Taghon, T; Taveirne, S; Van Acker, A; Van Ammel, E; Van Welden, S; Vandekerckhove, B; Vanhees, M	1
Deng, Z; Huang, X; Li, H; Liu, S; Ruan, Z; Wang, L; Wu, G; Yin, Y; Zhang, C; Zhou, X; Zhou, Y	1
Jian, J; Lafaille, JJ; Lin, J; Liu, CJ; Mundra, JJ; Tang, W; Tian, Q; Wei, F; Yu, X; Zhang, Y; Zhao, W	1
Barbosa, JS; Brito, GA; Correia, ES; Fernandes, GC; Goes, AC; Guimaraes, SB; Lima Júnior, RC; Pinto, FM; Ribeiro, RA; Rodrigues, LV	1
Bastos, JK; Di Stasi, LC; Seito, LN; Sforcin, JM	1
Baird, AC; Lawrance, IC; Lloyd, F	1
González, R; Martínez-Augustin, O; Mascaraque, C; Sánchez de Medina, F; Suárez, MD; Zarzuelo, A	1
He, X; He, Z; Lan, P; Lian, L; Xie, M; Zhu, J	1
Brenner, M; Wang, P; Yang, WL; Zhang, Y	1
Liu, TJ; Shi, YY; Zhao, Q; Zhu, T	1
Bai, A; Chen, J; Guo, Y; Liao, W; Lu, N	1
Cetinel, S; Dulger, FG; Ozkan, N; Sehirli, AO; Selman, S; Tetik, S; Yuksel, M	1
Bramhall, M; Brass, A; Cruickshank, S; Flórez-Vargas, O; Stevens, R	1
Ulutas, PA; Ural, M; Yaylali, A; Yildiz, G; Yildiz, Y	1
Castilho, AC; Di Stasi, LC; Quaglio, AE	1
Barrachina, MD; Calatayud, S; Cosín-Roger, J; Esplugues, JV; Hernández, C; Ortiz-Masiá, D	1
Al-Drees, A; Khalil, MS	1
Boehm, MF; Brahmachary, E; Brooks, J; Clemons, B; Dedman, H; Desale, HG; Martinborough, E; Peach, RJ; Powell, R; Roberts, E; Rosen, H; Scott, FL; Timony, GA	1
Bang, B; Lichtenberger, LM	1
Bai, AH; Chao, K; Chen, M; Cui, Y; Hu, JF; Li, M; Ng, SC; Wang, H; Yu, J; Yu, Q; Zhang, S	1
El-Salhy, M; Umezawa, K	1
Li, M; Li, Z; Liu, Y; Tang, L; Wang, Y; Wen, S	1
Araujo, SM; Bortolotto, VC; Cibin, FW; de Paula, MT; Jesse, CR; Poetini, MR; Prigol, M; Rodrigues, OE; Roman, SS; Spiazzi, C; Zarzecki, MS	1
Agrogiannis, G; Burris, DL; Butt, Z; DeLucca, JF; Dhoble, SJ; Douvi, G; Elliott, DM; Geiger, R; Gikas, A; Hollinger, KR; Hottor, HT; Jiang, W; Li, X; Little, SJ; Marohn, M; McCaskill, ML; Mehta, SR; Moore, AC; Papalois, A; Patel, RV; Pathak, MS; Patsouris, E; Rai, VK; Rais, R; Rathaiah, M; Rojas, C; Sapkota, M; Singh, N; Singh, PK; Singh, V; Slusher, BS; Smith, DM; Stathis, M; Syrmos, N; Thomas, AG; Triantafillidis, J; Vagianos, C; Venkatramu, V; Vornov, JJ; Wozniak, KM; Wyatt, TA; Zhai, H	1
Aksu, O; Aydin, B; Ciris, IM; Senol, A; Songur, N; Songur, Y; Sutcu, R	1
Handa, O; Higashimura, Y; Itoh, Y; Kamada, K; Katada, K; Mizushima, K; Naito, Y; Ohashi, Y; Okubo, T; Ozeki, M; Takagi, T; Tokunaga, M; Uchiyama, K; Ushiroda, C; Yasukawa, Z; Yoshikawa, T	1
Cui, YL; Gao, LN; Wang, GF; Wang, QS; Zhou, J	1
Ding, MX; Janyaro, H; Li, XJ; Shah, MK; Tahir, AH; Wan, J	1
El-Salhy, M; Gilja, OH; Mazzawi, T; Umezawa, K	1
Bloomfield, SA; Metzger, CE; Narayanan, A; Zawieja, DC	1
Chen, J; Chen, Z; Cui, G; Diao, H; Ding, Y; Li, L; Lu, C; Uede, T; Wang, L; Wei, Y; Wu, W; Yang, Y; Yu, T	1
Chen, YY; Fan, JY; Han, JY; Jiang, XG; Li, C; Liu, YY; Mu, HN; Sun, K; Wang, CS; Wang, MX; Yan, L	1
Chen, C; Chen, W; Du, X; Guo, L; Ju, R; Li, J; Wang, Y; Ye, C; Zhang, D; Zhu, L	1
Criado, G; Delgado, M; Diaz de la Guardia, R; García-Herrero, CM; Gonzalez-Rey, E; Lavoie, JR; Lopez-Millan, B; Menendez, P; O'Valle, F; Roca-Ho, H; Rosu-Myles, M	1
Babu, T; Date, AA; Ensign, LM; Gadiano, AJ; Halpert, G; Kanvinde, P; Ortiz, J; Rais, R; Slusher, BS; Thomas, AG; Zimmermann, SC	1
Gadaleta, RM; Garcia-Irigoyen, O; Moschetta, A	1
Dhaneshwar, SS; Sarkate, A	1
Abalo, A; Bernardazzi, C; Bobé, P; Coutinho, CMLM; Coutinho-Silva, R; de Souza, HSP; Figliuolo, VR; Kanellopoulos, J; Nanini, H; Safya, H; Savio, LEB	1
Amoussina, L; Atreya, I; Atreya, R; Becker, C; Biesterfeld, S; Brüstle, A; Galle, PR; Hoffman, A; Lehr, HA; Lohoff, M; Mudter, J; Mueller, C; Neurath, MF; Rose-John, S; Schenk, M; Weigmann, B; Wirtz, S; Yu, J	1
Medhi, B; Pandhi, P; Prakash, O; Saikia, UN	2
Avti, PK; Khanduja, KL; Medhi, B; Pandhi, P; Prakash, A; Saikia, UN	1
de Medina, FS; Martínez-Augustin, O; Merlos, M; Suárez, MD; Zarzuelo, A	1
Makhlof, A; Takeuchi, H; Tozuka, Y	1
Shan-Shan, Z; Yu-Lan, L	1
Cao, Q; Castrillon, DH; DePinho, RA; Liu, ZP; Peng, Y; Zhang, QJ; Zhou, W	1
Cai, TT; Gong, FY; Shen, Y; Sun, Y; Wu, XF; Wu, XX; Xu, Q; Yin, Y; Zhou, XB	1
Askenasy, N; Farkas, DL; Kaminitz, A; Sagiv, Y; Yarkoni, S	1
Chen, T; Ebersole, JL; Oz, HS	1
Chen, G; Feng, J; Gao, X; Han, G; Li, X; Li, Y; Lin, Z; Ma, Y; Shen, B; Wang, L; Wang, R	1
de Oliveira Costa, H; Franco, M; Miszputen, SJ; Oshima, CT; Paiotti, AP; Ribeiro, DA	1
Choi, HG; Choi, MK; Chung, IM; Kim, JA; Lee, JS; Park, SY; Park, YJ; Thapa, D; Yong, CS	1
Arber, N; Brazowski, E; Elinav, E; Hart, G; Maharshak, N; Margalit, R; Ron, E; Sagiv, A; Shachar, I; Zelman, E	1
Cardoso, CR; Cunha, FQ; Ferraz, DB; Godoi, DF; Provinciatto, PR; Silva, JS; Voltarelli, JC	1
Ammendola, A; Deml, L; Fitzpatrick, LR; Groeppel, M; Hamm, S; Hofmann, C; Leban, J; Lemstra, S; Small, JS	1
Flier, SN; Kalluri, R; Kokkotou, EG; Sugimoto, H; Tanjore, H; Zeisberg, M	1
Cui, W; Hu, ZM; Liu, JX; Mu, LZ; Wang, K; Wang, W; Yang, ZQ; Yin, XL; Yuan, CP; Yue, ZP	1
Chen, T; Jiang, H; Meng, S; Wu, W; Yang, X	1
Bueno, L; Chaumaz, G; De Ponti, F; Ferrier, L; Gaultier, E; Pascal, M; Schroedel, S; Schulte, AM; Serradeil-Le Gal, C; Ursino, MG; Vasina, V	1
Bahremand, A; Daneshmand, A; Dehpour, AR; Fakhfouri, G; Mohammadi, H; Mousavizadeh, K; Rahimian, R; Rasouli, MR	1
Bardella, MT; Bonura, A; Braidotti, P; Busca, G; Ciulla, MM; Elli, L; Ferrero, S; Maioli, C; Paliotti, R; Roncoroni, L; Terrani, C	1
Chen, XY; Fan, H; Liao, Y	1
Byrav, DS; Chakrabarti, A; Khanduja, KL; Medhi, B; Vaiphei, K	1
Di Stasi, LC; Fruet, AC; Salem, L; Witaicenis, A	1
Chen, G; Dou, Y; Gao, X; Guo, R; Han, G; Li, X; Li, Y; Shen, B; Wang, H; Wang, J; Wang, L; Wang, R; Xiao, H; Yang, Y	1
Adachi, R; Blumberg, RS; Glickman, JN; Hamilton, MJ; Krilis, SA; Lee, DM; Lyng, GD; Sinnamon, MJ; Stevens, RL; Wang, X; Xing, W	1
Arribas, B; Bailón, E; Camuesco, D; Comalada, M; Cueto-Sola, M; Gálvez, J; Garrido-Mesa, N; Nieto, A; Rodríguez-Cabezas, ME; Utrilla, P; Zarzuelo, A	1
Adorini, L; Danese, S; Gadaleta, RM; Klomp, LW; Laverny, G; Moschetta, A; Murzilli, S; Oldenburg, B; Penna, G; Renooij, W; Schipper, ME; Siersema, PD; van Erpecum, KJ; van Mil, SW; Willemsen, EC	1
Blum-Sperisen, S; Heupel, E; Philippe, D; Riedel, CU	1
Gilda, S; Harsulkar, A; Jagtap, S; Mahadik, K; Paradkar, A; Pawar, P; Ranjekar, P; Sharma, S	1
Alhouayek, M; Cani, PD; Delzenne, NM; Lambert, DM; Muccioli, GG	1
Booth, C; Burnet, M; Cipriani, S; Distrutti, E; Fiorucci, S; Guse, JH; Hahn, U; Mencarelli, A; Palladino, G; Renga, B; Tudor, G	1
Biancone, L; MacDonald, TT; Monteleone, G; Monteleone, I; Pallone, F; Rizzo, A; Sarra, M; Sica, G; Sileri, P	1
Chen, J; Choi, K; Mitra, S; Sarna, SK	1
Higgins, PD; Johnson, LA; Kim, K; McKenna, BJ; Moons, DS; Rubin, JM; Stidham, RW; Xu, J	1
Claes, IJ; De Keersmaecker, SC; Lebeer, S; Vanderleyden, J	1
Alican, I; Aydin, MS; Ercan, F; Karakoyun, B; Ogunc, AV; Uslu, U; Yuksel, M	1
Grunwitz, CR; Kaminski, BM; Radeke, HH; Reuter, KC; Stein, J; Steinhilber, D	1
Franco, M; Marchi, P; Miszputen, SJ; Neto, RA; Oshima, CT; Paiotti, AP; Ribeiro, DA; Silva, RM	1
Breton, J; Dewulf, J; Foligné, B; Peys, E; Pot, B; Van Hemel, J; Vandenkerckhove, J	1
Cardoso, CR; Cunha, Fde Q; da Silva, JS; Ferraz, DB; Godoi, DF; Provinciatto, PR; Silva, MJ; Voltarelli, JC	1
Boros, M; Erces, D; Ghyczy, M; Kaszaki, J; Kovács, T; Tiszlavicz, L; Tőkés, T; Varga, G; Vécsei, L	1
Bauer, C; Duewell, P; Endres, S; Lehr, HA; Schnurr, M	1
Bacquié, V; Bézirard, V; Braniste, V; Houdeau, E; Lencina, C; Lévêque, M; Ménard, S; Moussa, L; Salvador-Cartier, C; Théodorou, V	1
Crespo, I; Cuevas, MJ; González-Gallego, J; Marroni, N; Prause, C; San-Miguel, B; Tuñón, MJ	1
Brenna, Ø; Drozdov, I; Flatberg, A; Furnes, MW; Gustafsson, BI; Kidd, M; Mårvik, R; Nordrum, IS; Sandvik, AK; van Beelen Granlund, A; Zwiggelaar, RT	1
Bouma, G; Kaushiva, A; Strober, W	1
Ballinger, AB; Farthing, MJ; McCartney, SA; Vojnovic, I; Warner, TD	1
Cavicchi, M; Lamarque, D; Whittle, BJ	1
Desreumaux, P; Mercenier, A; Pavan, S	1
Aiba, Y; Ishikawa, H; Koga, Y; Mine, T; Shiba, T; Takagi, A; Ushiyama, A	1
Cadenas, V; Flores, J; Márquez, G; Martínez-A, C; Varona, R	1
Andoh, A; Araki, Y; Fujiyama, Y; Ishizuka, I; Koyama, S; Sasaki, M; Tsujikawa, T	1
Arumugam, TV; Fairlie, DP; Reid, RC; Shiels, IA; Taylor, SM; Woodruff, TM	1
Bennink, RJ; de Bruin, K; de Jonge, WJ; te Velde, AA; van Deventer, SJ; van Montfrans, C	1
Caucheteux-Rousseaux, C; Desreumaux, P; Dubuquoy, L; Foligne, B; Marceau, M; Simonet, M	1
Katsuno, T; Saito, Y; Suzuki, Y; Tanaga, TS; Tokumasa, A; Yokote, K	1
Andrade-Gordon, P; Beck, P; Bunnett, NW; Cellars, L; Cirino, G; Fiorucci, S; Hollenberg, MD; Mencarelli, A; Rizzo, G; Steinhoff, M; Swaminathan, S; Vergnolle, N; Wallace, JL	1
Jian, YT; Lai, ZS; Mai, GF; Wang, JD; Zhang, YL	1
Ishiguro, Y; Munakata, A; Sakuraba, H; Yamagata, K	1
Hasegawa, N; Mochizuki, M	1
Arumugam, TV; Fairlie, DP; Newman, ML; Reid, RC; Ross, PA; Shiels, IA; Taylor, SM; Woodruff, TM	1
Alcaraz, MJ; Busserolles, J; D'Auria, MV; Gomez-Paloma, L; Payá, M	1
Abad, C; Arranz, A; Garcia-Gómez, M; Gomariz, RP; Juarranz, Y; Leceta, J; Martinez, C; Rosignoli, F; Torroba, M	1
Mahadevan, IB; Manthey, HD; Pollitt, S; Proctor, LM; Shiels, IA; Stocks, SZ; Taylor, SM; Williams, HM; Woodruff, TM	1
Fukuda, Y; Hida, N; Hori, K; Kosaka, T; Matsumoto, T; Miwa, H; Ohda, Y; Tomita, T	1
Chang, CY; Choi, SY; Joh, JW; Jung, DY; Kim, EY; Kim, SJ; Kwon, GY; Lee, EN; Lee, J; Lee, KW; Lee, SK; Park, HJ	1
Ouyang, Q; Wang, X	1
Chung, HJ; Chung, MY; Kim, EJ; Kwon, JW; Lee, MG; Son, MW; Yoo, M	1
Cosenza, V; D'Argenio, G; Di Marzo, V; Scaglione, G; Sorrentini, I; Valenti, M	1
Das, G; Das, J; Shi, D	1
Chorny, A; Delgado, M; Ganea, D; Gonzalez-Rey, E; Sheibanie, AF; Varela, N	1
Burckel, A; Dennin, V; Drouault-Holowacz, S; Foligné, B; Goudercourt, D; Pot, B; Terpend, K	1
Cabane, C; Colombel, JF; Dérijard, B; Desreumaux, P; Dubuquoy, L; Gay, J; Malamut, G; Malapel, M; Tamboli, C	1
Adda, S; Dajee, M; De Vry, CG; Ehrhardt, RO; Garlapati, R; Hoffman, J; Kahoud, N; Komuves, L; Le, T; Lorenzana, C; Mai, K; McEvoy, LM; Muchamuel, T; Parham, C; Prasad, S; Schryver, B; Shyamsundar, R; Zhang, J	1
Choi, BK; Kang, WJ; Kim, KH; Kim, TY; Kim, YH; Kwon, BS; Lee, SK; Sakaguchi, S; Suh, JH	1
de Kort, F; Hommes, DW; Pronk, I; Sterrenburg, E; te Velde, AA; ten Kate, FJ; van Deventer, SJ	1
Bullens, DM; Ceuppens, JL; de Hertogh, G; Geboes, K; Rutgeerts, P; Shen, C; Van Assche, G	1
Bailón, E; Comalada, M; Concha, A; Gálvez, J; Lara-Villoslada, F; Nieto, A; Olivares, M; Peran, L; Sierra, S; Xaus, J; Zarzuelo, A	1
Adler, G; Bachem, M; Buttenschoen, K; Chiang, JY; Dikopoulos, N; Schmid, RM; Weidenbach, H	1
Emig, F; Ganea, D; Khayrullina, T; Sheibanie, AF; Tuma, R; Yen, JH; Zhang, M	1
Aharoni, R; Arnon, R; Brenner, O; Eilam, R; Sonego, H	1
Brzozowski, T; Budak, A; Drozdowicz, D; Konturek, SJ; Kwiecień, S; Mach, T; Pawlik, WW; Rudnicka-Sosin, L; Sliwowski, Z; Targosz, A; Trojanowska, D; Zwolińska-Wcisło, M	1
Arihiro, A; Kawada, M; Mizoguchi, E	1
Daniel, C; Dessein, R; Dewulf, J; Foligné, B; Marceau, M; Poiret, S; Pot, B; Simonet, M	1
Jiang, J; Xue, RY; Zhang, SC; Zhou, J; Zhou, K	1
Appleyard, CB; Isidro, AA; Pagán, B; Santiago, C	1
Brayden, DJ; Fallon, PG; Feighery, LM; O'Mahony, L; Smith, P	1
Eri, R; Kodumudi, KN; Srinivasan, M; Summerlin, DJ	1
Billerey-Larmonier, C; Ghishan, FK; Kiela, PR; Larmonier, N; Midura, AJ; Timmermann, B; Uno, JK	1
Kawai, M; Kurebayashi, Y; Ohashi, K; Sato, Y	1
Honda, K; Muta, H; Nakamura, K; Podack, ER; Shibata, K; Somada, S; Sun, X; Takayanagi, R; Tani, K; Yamada, H; Yoshihara, H; Yoshikai, Y	1
Liu, YL; Zhang, SS	1
Chen, Y; Lin, YZ; Song, YG	1
Amiji, MM; Bhavsar, MD	1
Pena, AS; Sminia, T; Soesatyo, M; van der Ende, M; van Rees, EP	1
Bueno, L; Fargeas, MJ; Fioramonti, J; More, J; Theodorou, V; Wal, JM	1
Anthony, D; Boulos, P; Sams, V; Savage, F	1
Boughton-Smith, NK; Evans, SM; Moncada, S; Whittle, BJ	1
Palmen, MJ; Peña, AS; van der Ende, MB; van Rees, EP	1
Hikasa, Y; Hori, K; Nishikawa, M; Shimoyama, T; Tanida, N	1
Carter, L; Wallace, JL	1
Camerini, R; Caputi, AP; Graziani, P; Squadrito, F; Zingarelli, B	1
Belogi, L; Cavallo, G; Croce, C; Guida, G; Modesti, A; Santiangeli, C; Tubaro, E	1
Sminia, T; Soesatyo, M; van der Ende, M; van Rees, EP	1
Dunn, C; Sun, FF; Wong, PY; Yin, K; Yue, G	1
Beagley, KW; Black, CA; Cong, Y; Elson, CO; Fujihashi, K; Kiyono, H; McGhee, JR; Ridwan, BW; Sharmanov, AT; Tennyson, GS	1
Fukuta, Y; Ikeda, A; Inui, K; Kameda, H; Kokuba, Y; Sato, M	1
Chambers, TJ; Chow, JW; Lin, CL; Moniz, C	1
Gálvez, J	1
Evangelista, S; Maggi, M; Renzetti, AR	1
Dayan, D; Eyal, A; Rabau, M	1
Alexopoulou, L; Fuss, I; Haralambous, S; Kollias, G; Meyer zum Büschenfelde, KH; Neurath, MF; Pasparakis, M; Strober, W	1
Aoyama, T; Iga, T; Kotaki, H; Nakajima, K; Sawada, Y; Shibuya, F; Shimada, S	1
Kang, HK; Kim, BK; Kim, WB; Ko, JI; Son, M	1
Baginski, TJ; Dykens, JA	1
Föhr, N; Günthert, U; Schwärzler, C; Wittig, B; Zöller, M	1
Inomata, Y; Ito, K; Makino, M; Tabata, K	1
Doh, HM; Kim, BK; Kim, WB; Ko, JI; Park, TS; Shim, MJ; Son, MW	1
Dohi, T; Fujihashi, K; Iwatani, K; Kiyono, H; McGhee, JR; Rennert, PD	1
Günthert, U	1
Cho, H; Kim, CY; Kim, WB; Kim, YS; Ko, JI; Son, M; Song, IS; Yoo, M	1
Cho, CH; Guo, X; Ko, JK; Wang, WP	1
Bhogal, R; Bird, J; Brampton, C; Chander, C; Parsons, ME; Sykes, AP; Whelan, C	1
Jacobasch, G; Kruschewski, M; Schmehl, K; Schmiedl, D	1
Hogaboam, CM; Huang, JQ; Hunt, RH; Padol, I	1
Ardite, E; Fernández-Checa, JC; Panés, J; Piqué, JM; Romero, FJ; Sans, M	1
Günthert, U; Johansson, B; Schwärzler, C; Wittig, BM; Zöller, M	1
Brampton, C; Chander, CL; Klee, S; Parsons, ME; Sykes, AP; Whelan, C	1
Chow, JW; Lin, CL; Moniz, C	1
Cho, C; Guo, X; Ko, JK; Lam, S; Liu, ES; Wong, BC; Ye, Y	1
Bossone, C; Hosseini, JM; Piñeiro-Carrero, V; Shea-Donohue, T	1
Chin, JE; Krzesicki, RF; Lai, PS; Nagele, RG; Sun, FF; Tong, DM; Wong, PY; Yin, K; Yue, G	1
Pan, G; Qian, J; Zhu, F	1
Buhr, HJ; Foitzik, T; Hübotter, A; Kruschewski, M; Perez-Cantó, A	1
Kankuri, E; Korpela, R; Moilanen, E; Paakkari, I; Vaali, K; Vapaatalo, H	1
Buergelt, CD; Merritt, AM; Sanchez, LC	1
Barth, S; Diehl, V; Ecker, KW; Engert, A; Huhn, M; Jüngling, B; Mueller-Molaian, I; Pfister, K; Sasse, S; Stallmach, A; Wittig, BM; Zeitz, M	1
Selve, N	1
Buntrock, P; Gerber, G; Grune, T; Schneider, W; Siems, WG; Werner, A	1
Boughton-Smith, NK; Wallace, JL; Whittle, BJ	1

Reviews

9 review(s) available for trinitrobenzenesulfonic acid and Bowel Diseases, Inflammatory

Article	Year
Inflammatory Bowel Disease: A Review of Pre-Clinical Murine Models of Human Disease. International journal of molecular sciences, 2022, Aug-19, Volume: 23, Issue:16 Topics: Animals; Chronic Disease; Colitis; Dextran Sulfate; Disease Models, Animal; Humans; Inflammatory Bowel Diseases; Mice; Trinitrobenzenesulfonic Acid	2022
Human Relevance of Preclinical Studies on the Skeletal Impact of Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Calcified tissue international, 2021, Volume: 108, Issue:6 Topics: Animals; Bone Diseases, Metabolic; Colitis; Dextran Sulfate; Disease Models, Animal; Humans; Inflammatory Bowel Diseases; Trinitrobenzenesulfonic Acid	2021
Quality of methods reporting in animal models of colitis. Inflammatory bowel diseases, 2015, Volume: 21, Issue:6 Topics: Animals; Checklist; Colitis; Dextran Sulfate; Disease Models, Animal; Humans; Inflammatory Bowel Diseases; Interleukin-10; Leukocyte Common Antigens; Research Design; Trinitrobenzenesulfonic Acid	2015
Lessons from probiotic-host interaction studies in murine models of experimental colitis. Molecular nutrition & food research, 2011, Volume: 55, Issue:10 Topics: Animals; Colitis; Colitis, Ulcerative; Dextran Sulfate; Disease Models, Animal; Humans; Inflammatory Bowel Diseases; Interleukin-10; Mice; Mice, Inbred Strains; Mice, Mutant Strains; Probiotics; Trinitrobenzenesulfonic Acid	2011
Assessment of anticolitic drugs in the trinitrobenzene sulfonic acid (TNBS) rat model of inflammatory bowel disease. Methods in molecular biology (Clifton, N.J.), 2003, Volume: 225 Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Arginine; Blotting, Western; Colitis; Disease Models, Animal; Drug Evaluation, Preclinical; Enzyme Inhibitors; Inflammatory Bowel Diseases; Injections, Subcutaneous; Instillation, Drug; Male; Models, Animal; Neutrophils; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Peroxidase; Rats; Rats, Wistar; Trinitrobenzenesulfonic Acid	2003
Insights from advances in research of chemically induced experimental models of human inflammatory bowel disease. World journal of gastroenterology, 2007, Nov-14, Volume: 13, Issue:42 Topics: Animals; Cytokines; Dextran Sulfate; Humans; Inflammatory Bowel Diseases; NF-kappa B; Oxazolone; Receptors, Tumor Necrosis Factor; T-Lymphocytes; Toll-Like Receptors; Trinitrobenzenesulfonic Acid	2007
Therapeutic potential of Yersinia anti-inflammatory components. Advances in experimental medicine and biology, 2007, Volume: 603 Topics: Animals; Antigens, Bacterial; Colitis; Humans; Inflammation; Inflammatory Bowel Diseases; Lactococcus lactis; Mice; Pore Forming Cytotoxic Proteins; Trinitrobenzenesulfonic Acid; Virulence Factors; Yersinia	2007
Importance of CD44 variant isoforms in mouse models for inflammatory bowel disease. Current topics in microbiology and immunology, 1999, Volume: 246 Topics: Animals; Autoimmune Diseases; Disease Models, Animal; Genetic Variation; Humans; Hyaluronan Receptors; Inflammatory Bowel Diseases; Mice; Th1 Cells; Trinitrobenzenesulfonic Acid	1999
Dietary resistant starch and chronic inflammatory bowel diseases. International journal of colorectal disease, 1999, Volume: 14, Issue:4-5 Topics: Animals; Apoptosis; Bacterial Translocation; Butyrates; Colon; Dietary Carbohydrates; Fatty Acids, Volatile; Humans; Inflammatory Bowel Diseases; Intestinal Absorption; Rats; Rats, Sprague-Dawley; Starch; Trinitrobenzenesulfonic Acid	1999

Trials

2 trial(s) available for trinitrobenzenesulfonic acid and Bowel Diseases, Inflammatory

Article	Year
Defective expression of SIRT1 contributes to sustain inflammatory pathways in the gut. Mucosal immunology, 2014, Volume: 7, Issue:6 Topics: Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Female; Gene Expression Regulation, Enzymologic; Humans; Inflammatory Bowel Diseases; Infliximab; Interferon-gamma; Interleukins; Intestines; Male; Mice; Middle Aged; Oxazolone; Sirtuin 1; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha	2014
A potent human C5a receptor antagonist protects against disease pathology in a rat model of inflammatory bowel disease. Journal of immunology (Baltimore, Md. : 1950), 2003, Nov-15, Volume: 171, Issue:10 Topics: Animals; Antibodies, Monoclonal; Body Weight; Colon; Disease Models, Animal; Eating; Edema; Humans; Inflammatory Bowel Diseases; Infliximab; Male; Peptides, Cyclic; Peroxidase; Prednisolone; Rats; Rats, Wistar; Receptor, Anaphylatoxin C5a; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha	2003

Article

Year

Defective expression of SIRT1 contributes to sustain inflammatory pathways in the gut.

Mucosal immunology, 2014, Volume: 7, Issue:6

Topics: Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Female; Gene Expression Regulation, Enzymologic; Humans; Inflammatory Bowel Diseases; Infliximab; Interferon-gamma; Interleukins; Intestines; Male; Mice; Middle Aged; Oxazolone; Sirtuin 1; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha

2014

A potent human C5a receptor antagonist protects against disease pathology in a rat model of inflammatory bowel disease.

Journal of immunology (Baltimore, Md. : 1950), 2003, Nov-15, Volume: 171, Issue:10

Topics: Animals; Antibodies, Monoclonal; Body Weight; Colon; Disease Models, Animal; Eating; Edema; Humans; Inflammatory Bowel Diseases; Infliximab; Male; Peptides, Cyclic; Peroxidase; Prednisolone; Rats; Rats, Wistar; Receptor, Anaphylatoxin C5a; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha

2003

Other Studies

269 other study(ies) available for trinitrobenzenesulfonic acid and Bowel Diseases, Inflammatory

Article	Year
Bacteria-Derived Compatible Solutes Ectoine and 5α-Hydroxyectoine Act as Intestinal Barrier Stabilizers to Ameliorate Experimental Inflammatory Bowel Disease. Journal of natural products, 2015, Jun-26, Volume: 78, Issue:6 Topics: Amino Acids, Diamino; Animals; Bacteria; Colitis; Colon; Egypt; Glutathione; Humans; Inflammatory Bowel Diseases; Intercellular Adhesion Molecule-1; Interleukin-1beta; Intestines; Male; Molecular Structure; Peroxidase; Rats; Rats, Wistar; Solutions; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha	2015
Intracolic ultrasound molecular imaging: a novel method for assessing colonic tumor necrosis factor-α expression in inflammatory bowel disease. Molecular medicine (Cambridge, Mass.), 2021, 09-23, Volume: 27, Issue:1 Topics: Animals; Colitis; Colon; Disease Models, Animal; Fluorescent Antibody Technique; Gene Expression; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Linear Models; Male; Mice, Inbred BALB C; Reproducibility of Results; Reverse Transcriptase Polymerase Chain Reaction; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha; Ultrasonography	2021
Protein Kinase CK2 Acts as a Molecular Brake to Control NADPH Oxidase 1 Activation and Colon Inflammation. Cellular and molecular gastroenterology and hepatology, 2022, Volume: 13, Issue:4 Topics: Animals; Casein Kinase II; Colitis; Inflammation; Inflammatory Bowel Diseases; Mice; NADPH Oxidase 1; Reactive Oxygen Species; Trinitrobenzenesulfonic Acid	2022
Mesenchymal Stem Cells Alleviate Inflammatory Bowel Disease Via Tr1 Cells. Stem cell reviews and reports, 2022, Volume: 18, Issue:7 Topics: Animals; Colitis; Dioxygenases; Humans; Inflammatory Bowel Diseases; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice; T-Lymphocytes, Regulatory; Trinitrobenzenesulfonic Acid	2022
Possible Curative Effects of Boric Acid and Bacillus clausii Treatments on TNBS-Induced Ulcerative Colitis in Rats. Biological trace element research, 2023, Volume: 201, Issue:3 Topics: Animals; Antioxidants; Bacillus clausii; Colitis, Ulcerative; Colon; Disease Models, Animal; Inflammatory Bowel Diseases; Interleukins; Peroxidase; Rats; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha	2023
Chronic Experimental Model of TNBS-Induced Colitis to Study Inflammatory Bowel Disease. International journal of molecular sciences, 2022, Apr-25, Volume: 23, Issue:9 Topics: Animals; Chronic Disease; Colitis; Colon; Disease Models, Animal; Ethanol; Female; Inflammatory Bowel Diseases; Mice; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha	2022
Endoplasmic reticulum stress contributed to inflammatory bowel disease by activating p38 MAPK pathway. European journal of histochemistry : EJH, 2022, May-23, Volume: 66, Issue:2 Topics: Animals; Colitis; Endoplasmic Reticulum Stress; Humans; Inflammatory Bowel Diseases; Interleukin-8; Mice; p38 Mitogen-Activated Protein Kinases; Trinitrobenzenesulfonic Acid; Tunicamycin	2022
Polydatin alleviates DSS- and TNBS-induced colitis by suppressing Th17 cell differentiation via directly inhibiting STAT3. Phytotherapy research : PTR, 2022, Volume: 36, Issue:9 Topics: Animals; Cell Differentiation; Colitis; Colon; Dextran Sulfate; Disease Models, Animal; Glucosides; Inflammatory Bowel Diseases; Mice; Mice, Inbred C57BL; STAT3 Transcription Factor; Stilbenes; T-Lymphocytes, Regulatory; Th17 Cells; Trinitrobenzenesulfonic Acid	2022
Oral supplementation with selected Lactobacillus acidophilus triggers IL-17-dependent innate defense response, activation of innate lymphoid cells type 3 and improves colitis. Scientific reports, 2022, 10-20, Volume: 12, Issue:1 Topics: Animals; Bifidobacterium animalis; Colitis; Enterobacteriaceae Infections; Immunity, Innate; Inflammation; Inflammatory Bowel Diseases; Interleukin-17; Lactobacillus acidophilus; Lymphocytes; Mice; Probiotics; Trinitrobenzenesulfonic Acid	2022
Comparison of the safety and efficacy of fingolimod and tofacitinib in the zebrafish model of colitis. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2022, Volume: 170 Topics: Animals; Colitis; Fingolimod Hydrochloride; Inflammatory Bowel Diseases; Myeloid Differentiation Factor 88; Trinitrobenzenesulfonic Acid; Zebrafish	2022
Electrolyzed Hydrogen Water Alleviates Abdominal Pain through Suppression of Colonic Tissue Inflammation in a Rat Model of Inflammatory Bowel Disease. Nutrients, 2022, Oct-22, Volume: 14, Issue:21 Topics: Abdominal Pain; Animals; Colitis; Colon; Hydrogen; Inflammation; Inflammatory Bowel Diseases; Rats; Reactive Oxygen Species; Trinitrobenzenesulfonic Acid; Water	2022
Efficacy and safety of erythropoietin in a chronic model of Inflammatory Bowel Disease. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2022, Volume: 156 Topics: Animals; Anti-Inflammatory Agents; Chronic Disease; Colitis; Erythropoietin; Graft vs Host Disease; Inflammatory Bowel Diseases; Mice; Trinitrobenzenesulfonic Acid	2022
Radix Panacis quinquefolii Extract Ameliorates Inflammatory Bowel Disease through Inhibiting Inflammation. Chinese journal of integrative medicine, 2023, Volume: 29, Issue:9 Topics: Animals; Anti-Inflammatory Agents; Colitis; Disease Models, Animal; Inflammation; Inflammatory Bowel Diseases; Lipopolysaccharides; Trinitrobenzenesulfonic Acid; Zebrafish	2023
Effect of exogenous galectin-9, a natural TIM-3 ligand, on the severity of TNBS- and DSS-induced colitis in mice. International immunopharmacology, 2023, Volume: 115 Topics: Animals; Colitis; Dextran Sulfate; Disease Models, Animal; Galectins; Hepatitis A Virus Cellular Receptor 2; Inflammatory Bowel Diseases; Interleukin-6; Ligands; Mice; Mice, Inbred C57BL; NF-kappa B; Toll-Like Receptor 4; Trinitrobenzenesulfonic Acid	2023
Electroacupuncture Alleviates 46-Trinitrobenzene Sulfonic Acid-Induced Visceral Pain via the Glutamatergic Pathway in the Prefrontal Cortex. Oxidative medicine and cellular longevity, 2023, Volume: 2023 Topics: Animals; Electroacupuncture; Glutamates; Inflammatory Bowel Diseases; Prefrontal Cortex; Quality of Life; Rats; Rats, Sprague-Dawley; Trinitrobenzenesulfonic Acid; Visceral Pain	2023
Response Variability to Drug Testing in Two Models of Chemically Induced Colitis. International journal of molecular sciences, 2023, Mar-29, Volume: 24, Issue:7 Topics: Animals; Colitis; Dextran Sulfate; Disease Models, Animal; Female; Humans; Inflammatory Bowel Diseases; Male; Mice; Trinitrobenzenesulfonic Acid	2023
Lactic Acid Bacteria Isolated from Human Breast Milk Improve Colitis Induced by 2,4,6-Trinitrobenzene Sulfonic Acid by Inhibiting NF-κB Signaling in Mice. Journal of microbiology and biotechnology, 2023, Aug-28, Volume: 33, Issue:8 Topics: Animals; Colitis; Colon; Cyclooxygenase 2; Cytokines; Female; Humans; Inflammatory Bowel Diseases; Lactobacillales; Mice; Milk, Human; NF-kappa B; Tight Junction Proteins; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha	2023
Human umbilical cord mesenchymal stem cells alleviated TNBS-induced colitis in mice by restoring the balance of intestinal microbes and immunoregulation. Life sciences, 2023, Dec-01, Volume: 334 Topics: Animals; Colitis; Cytokines; Disease Models, Animal; Humans; Immunity; Inflammatory Bowel Diseases; Mesenchymal Stem Cells; Mice; T-Lymphocytes, Regulatory; Trinitrobenzenesulfonic Acid; Umbilical Cord	2023
Evaluation of the effect of liposomes loaded with chlorogenic acid in treatment of 2,4,6-trinitrobenzenesulfonic acid-induced murine colitis. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2019, Volume: 70, Issue:2 Topics: Animals; Anti-Inflammatory Agents; Chlorogenic Acid; Colitis; Colon; Disease Models, Animal; Inflammatory Bowel Diseases; Liposomes; Male; Mesalamine; Mice; Mice, Inbred BALB C; Peroxidase; Quality of Life; Trinitrobenzenesulfonic Acid	2019
Changes in colonic contractility in response to inflammatory bowel disease: Long-term assessment in a model of TNBS-induced inflammation in rats. Life sciences, 2019, Nov-01, Volume: 236 Topics: Animals; Colitis; Disease Models, Animal; Inflammation; Inflammatory Bowel Diseases; Intestinal Mucosa; Male; Muscle Contraction; Rats; Rats, Wistar; Trinitrobenzenesulfonic Acid	2019
Amelioration of colitis in mice by Leuconostoc lactis EJ-1 by M1 to M2 macrophage polarization. Microbiology and immunology, 2020, Volume: 64, Issue:2 Topics: Animals; Colitis; Colon; Disease Models, Animal; Inflammatory Bowel Diseases; Interleukin-10; Interleukin-1beta; Interleukin-6; Leuconostoc; Lipopolysaccharides; Macrophages, Peritoneal; Mice; NF-kappa B; Plants, Edible; Signal Transduction; Trinitrobenzenesulfonic Acid	2020
Exosomes from mesenchymal stromal cells reduce murine colonic inflammation via a macrophage-dependent mechanism. JCI insight, 2019, 12-19, Volume: 4, Issue:24 Topics: Animals; Colon; Dextran Sulfate; Disease Models, Animal; Down-Regulation; Exosomes; Humans; Inflammation Mediators; Inflammatory Bowel Diseases; Interleukin-10; Intestinal Mucosa; Macrophage Activation; Macrophages; Male; Mesenchymal Stem Cells; Mice; Trinitrobenzenesulfonic Acid	2019
Aqueous Extract of Brazilian Berry ( Nutrients, 2019, Nov-15, Volume: 11, Issue:11 Topics: Animals; Anti-Inflammatory Agents; Bifidobacterium; Colitis; Fruit; Inflammatory Bowel Diseases; Intestinal Mucosa; Lactobacillus; Myrtaceae; Plant Extracts; Rats; Rats, Wistar; Trinitrobenzenesulfonic Acid	2019
Sauchinone ameliorates intestinal inflammation and promotes Th17 cell production of IL-10 via Blimp-1. Biochemical and biophysical research communications, 2020, 02-05, Volume: 522, Issue:2 Topics: Animals; Benzopyrans; Colitis; Dioxoles; Humans; Inflammation; Inflammatory Bowel Diseases; Interleukin-10; Intestines; Mice; Positive Regulatory Domain I-Binding Factor 1; Signal Transduction; Th17 Cells; Trinitrobenzenesulfonic Acid	2020
Immunomodulatory Effect of Urine-derived Stem Cells on Inflammatory Bowel Diseases via Downregulating Th1/Th17 Immune Responses in a PGE2-dependent Manner. Journal of Crohn's & colitis, 2020, Jun-19, Volume: 14, Issue:5 Topics: Adult; Animals; Bone Marrow Cells; Cell Differentiation; Cell Proliferation; Cells, Cultured; Coculture Techniques; Colitis; Cyclooxygenase 2; Cytokines; Dextran Sulfate; Dinoprostone; Down-Regulation; Gene Knockdown Techniques; Humans; Immunomodulation; Inflammatory Bowel Diseases; Lymphocyte Activation; Male; Mesenchymal Stem Cells; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Phytohemagglutinins; Stem Cell Transplantation; Stem Cells; Th1 Cells; Th17 Cells; Trinitrobenzenesulfonic Acid; Urine; Young Adult	2020
Altered microbial community structure in PI3Kγ knockout mice with colitis impeding relief of inflammation: Establishment of new indices for intestinal microbial disorder. International immunopharmacology, 2020, Volume: 79 Topics: Animals; Class Ib Phosphatidylinositol 3-Kinase; Colitis; Colon; Cytokines; Disease Models, Animal; Female; Humans; Inflammatory Bowel Diseases; Mice; Mice, Inbred BALB C; Mice, Knockout; Microbiota; RNA, Ribosomal, 16S; Signal Transduction; Trinitrobenzenesulfonic Acid	2020
Low-dose curcumin reduced TNBS-associated mucin depleted foci in mice by scavenging superoxide anion and lipid peroxides, rebalancing matrix NO synthase and aconitase activities, and recoupling mitochondria. Inflammopharmacology, 2020, Volume: 28, Issue:4 Topics: Aconitate Hydratase; Animals; Apoptosis; Colitis; Colon; Curcumin; Inflammatory Bowel Diseases; Intestinal Mucosa; Lipid Peroxides; Male; Mice; Mitochondria; Mucins; Nitric Oxide Synthase; Oxidation-Reduction; Peroxidase; Reactive Oxygen Species; Superoxides; Trinitrobenzenesulfonic Acid	2020
Therapeutic effects of combination of platelet lysate and sulfasalazine administration in TNBS-induced colitis in rat. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2020, Volume: 125 Topics: Animals; Apoptosis; Blood Platelets; Colitis; Combined Modality Therapy; Cytokines; Disease Models, Animal; Gastrointestinal Agents; Inflammatory Bowel Diseases; Male; NF-kappa B; Rats; Rats, Wistar; Signal Transduction; Sulfasalazine; Treatment Outcome; Trinitrobenzenesulfonic Acid	2020
miR-340 affects sauchinone inhibition of Th17 cell differentiation and promotes intestinal inflammation in inflammatory bowel disease. Biochemical and biophysical research communications, 2020, 06-11, Volume: 526, Issue:4 Topics: Base Sequence; Benzopyrans; Cell Cycle Proteins; Cell Differentiation; Colitis; Dioxoles; Disease Susceptibility; DNA-Binding Proteins; Down-Regulation; Forkhead Transcription Factors; Humans; Inflammation; Inflammatory Bowel Diseases; Intestines; MicroRNAs; Nuclear Proteins; Severity of Illness Index; T-Lymphocytes, Regulatory; Th1 Cells; Th17 Cells; Trinitrobenzenesulfonic Acid; Up-Regulation	2020
Transcriptome Based Profiling of the Immune Cell Gene Signature in Rat Experimental Colitis and Human IBD Tissue Samples. Biomolecules, 2020, 06-29, Volume: 10, Issue:7 Topics: Adult; Aged; Animals; Biopsy; Colitis; Colon; Disease Models, Animal; Female; Gene Expression Profiling; Gene Expression Regulation; Gene Regulatory Networks; Humans; Inflammatory Bowel Diseases; Male; Middle Aged; Rats; Sequence Analysis, RNA; Trinitrobenzenesulfonic Acid	2020
Electroacupuncture intervention of visceral hypersensitivity is involved in PAR-2-activation and CGRP-release in the spinal cord. Scientific reports, 2020, 07-07, Volume: 10, Issue:1 Topics: Animals; Calcitonin Gene-Related Peptide; Electroacupuncture; Female; Goats; Ileitis; Ileum; Inflammatory Bowel Diseases; Male; Proto-Oncogene Proteins c-fos; Receptor, PAR-2; Spinal Cord; Trinitrobenzenesulfonic Acid	2020
Betulinic acid hydroxamate prevents colonic inflammation and fibrosis in murine models of inflammatory bowel disease. Acta pharmacologica Sinica, 2021, Volume: 42, Issue:7 Topics: Animals; Anti-Inflammatory Agents; Betulinic Acid; Caco-2 Cells; Colon; Dextran Sulfate; Fibrosis; Gastrointestinal Agents; Gene Expression; Humans; Hydroxamic Acids; Inflammation; Inflammatory Bowel Diseases; Intestinal Mucosa; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; NIH 3T3 Cells; Pentacyclic Triterpenes; Trinitrobenzenesulfonic Acid	2021
In Vitro Characterization of Gut Microbiota-Derived Commensal Strains: Selection of Cells, 2020, 09-16, Volume: 9, Issue:9 Topics: Adult; Animals; Bacteroidetes; Caco-2 Cells; Colitis; Disease Models, Animal; DNA, Bacterial; Feces; Female; Gastrointestinal Microbiome; Humans; Infant, Newborn; Inflammatory Bowel Diseases; Intestinal Mucosa; Mice; Mice, Inbred BALB C; Real-Time Polymerase Chain Reaction; T-Lymphocytes, Regulatory; Trinitrobenzenesulfonic Acid	2020
DNA Damage-Regulated Autophagy Modulator 1 (DRAM1) Mediates Autophagy and Apoptosis of Intestinal Epithelial Cells in Inflammatory Bowel Disease. Digestive diseases and sciences, 2021, Volume: 66, Issue:10 Topics: Adolescent; Adult; Aged; Animals; Apoptosis; Autophagy; Child; Colitis; Dextran Sulfate; Epithelial Cells; Female; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Male; Membrane Proteins; Mice; Mice, Inbred BALB C; Middle Aged; Trinitrobenzenesulfonic Acid; Up-Regulation; Young Adult	2021
Anti-inflammatory and antibacterial effects of human cathelicidin active fragment KR-12 in the mouse models of colitis: a novel potential therapy of inflammatory bowel diseases. Pharmacological reports : PR, 2021, Volume: 73, Issue:1 Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antimicrobial Cationic Peptides; Cathelicidins; Colitis; Colon; Dextran Sulfate; Feces; Humans; Inflammatory Bowel Diseases; Male; Mice; Mice, Inbred BALB C; Peptide Fragments; Peroxidase; Trinitrobenzenesulfonic Acid	2021
2,4,6-trinitrobenzenesulfonic acid-induced colitis in Rattus norgevicus: a categorization proposal. Experimental animals, 2021, May-13, Volume: 70, Issue:2 Topics: Animals; Colitis; Disease Models, Animal; Humans; Inflammatory Bowel Diseases; Male; Rats; Rats, Wistar; Retrospective Studies; Trinitrobenzenesulfonic Acid	2021
Linagliptin mitigates experimental inflammatory bowel disease in rats by targeting inflammatory and redox signaling. Life sciences, 2021, May-15, Volume: 273 Topics: Animals; Colitis; Cytokines; Hypoglycemic Agents; Inflammation; Inflammatory Bowel Diseases; Janus Kinase 2; Linagliptin; Male; NF-kappa B; Oxidation-Reduction; Rats; Rats, Wistar; Signal Transduction; STAT3 Transcription Factor; Trinitrobenzenesulfonic Acid	2021
HLA-Restriction of Human Treg Cells Is Not Required for Therapeutic Efficacy of Low-Dose IL-2 in Humanized Mice. Frontiers in immunology, 2021, Volume: 12 Topics: Animals; HLA Antigens; Humans; Inflammatory Bowel Diseases; Interleukin-2; Mice; Mice, Inbred NOD; T-Lymphocyte Subsets; T-Lymphocytes, Regulatory; Trinitrobenzenesulfonic Acid	2021
Inhibitor of apoptosis-stimulating p53 protein protects against inflammatory bowel disease in mice models by inhibiting the nuclear factor kappa B signaling. Clinical and experimental immunology, 2021, Volume: 205, Issue:2 Topics: Adult; Animals; Anti-Inflammatory Agents; Apoptosis; Colitis; Colon; Cytokines; Dextran Sulfate; Disease Models, Animal; Humans; Inflammation; Inflammatory Bowel Diseases; Male; Mice; Mice, Inbred C57BL; Middle Aged; NF-kappa B; Signal Transduction; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha; Tumor Suppressor Protein p53	2021
Protection by microRNA-7a-5p Antagomir Against Intestinal Mucosal Injury Related to the JNK Pathway in TNBS-Induced Experimental Colitis. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2021, Volume: 32, Issue:5 Topics: Animals; Antagomirs; Colitis; Disease Models, Animal; Inflammatory Bowel Diseases; Intestinal Mucosa; Intestines; Male; MAP Kinase Signaling System; Mice; MicroRNAs; Trinitrobenzenesulfonic Acid	2021
Dietary salt exacerbates intestinal fibrosis in chronic TNBS colitis via fibroblasts activation. Scientific reports, 2021, 07-23, Volume: 11, Issue:1 Topics: Animals; Colitis; Diet; Disease Models, Animal; Extracellular Matrix Proteins; Fibroblasts; Fibrosis; Humans; Inflammation; Inflammatory Bowel Diseases; Intestinal Mucosa; Intestines; Myofibroblasts; Rats; Salts; Trinitrobenzenesulfonic Acid	2021
Comparison of anti-inflammatory activities of an anthocyanin-rich fraction from Portuguese blueberries (Vaccinium corymbosum L.) and 5-aminosalicylic acid in a TNBS-induced colitis rat model. PloS one, 2017, Volume: 12, Issue:3 Topics: Animals; Anthocyanins; Anti-Inflammatory Agents; Antioxidants; Blueberry Plants; Colitis; Colon; Cyclooxygenase 2; Inflammation; Inflammatory Bowel Diseases; Intestinal Mucosa; Intestines; Male; Mesalamine; Nitric Oxide Synthase Type II; Rats; Rats, Wistar; Trinitrobenzenesulfonic Acid	2017
Protective effects of tranilast on experimental colitis in rats. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2017, Volume: 90 Topics: Animals; Anti-Inflammatory Agents; Colitis; Colon; Disease Models, Animal; Inflammatory Bowel Diseases; Intestinal Mucosa; Male; ortho-Aminobenzoates; Peroxidase; Protective Agents; Rats; Rats, Wistar; Trinitrobenzenesulfonic Acid	2017
Combined Treatment with Hyaluronic Acid and Mesalamine Protects Rats from Inflammatory Bowel Disease Induced by Intracolonic Administration of Trinitrobenzenesulfonic Acid. Molecules (Basel, Switzerland), 2017, May-30, Volume: 22, Issue:6 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 2; Cytokines; Disease Models, Animal; Hyaluronic Acid; Inflammation Mediators; Inflammatory Bowel Diseases; Intestinal Mucosa; Male; Mesalamine; Peroxidase; Protective Agents; Rats; Trinitrobenzenesulfonic Acid	2017
Discovery and structure-activity relationship studies of 2-benzylidene-2,3-dihydro-1H-inden-1-one and benzofuran-3(2H)-one derivatives as a novel class of potential therapeutics for inflammatory bowel disease. European journal of medicinal chemistry, 2017, Sep-08, Volume: 137 Topics: Animals; Benzofurans; Colitis; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Discovery; Female; HT29 Cells; Humans; Indenes; Inflammatory Bowel Diseases; Molecular Structure; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Transcription Factor AP-1; Trinitrobenzenesulfonic Acid; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; U937 Cells	2017
The Probiotic VSL#3 Modulates Colonic Macrophages, Inflammation, and Microflora in Acute Trinitrobenzene Sulfonic Acid Colitis. The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society, 2017, Volume: 65, Issue:8 Topics: Acute Disease; Animals; Chronic Disease; Colon; Cytokines; Feces; Inflammatory Bowel Diseases; Intestinal Mucosa; Macrophages; Male; Probiotics; Rats, Sprague-Dawley; Tight Junction Proteins; Trinitrobenzenesulfonic Acid	2017
Elevated fibrinogen‑like protein 2 in TNBS‑induced colitis mice: Association with Th17 and regulatory T cells. Molecular medicine reports, 2017, Volume: 16, Issue:3 Topics: Animals; Colitis; Colon; Cytokines; Disease Models, Animal; Fibrinogen; Gene Expression Regulation; Immunohistochemistry; Inflammation; Inflammation Mediators; Inflammatory Bowel Diseases; Male; Mice, Inbred BALB C; Spleen; T-Lymphocytes, Regulatory; Th17 Cells; Transcription Factors; Trinitrobenzenesulfonic Acid	2017
Bifidobacterium longum affects the methylation level of forkhead box P3 promoter in 2, 4, 6-trinitrobenzenesulphonic acid induced colitis in rats. Microbial pathogenesis, 2017, Volume: 110 Topics: Animals; Bifidobacterium longum; Colitis; Disease Models, Animal; DNA Methylation; Forkhead Transcription Factors; Inflammatory Bowel Diseases; Leukocytes, Mononuclear; Probiotics; Promoter Regions, Genetic; Rats; Rats, Sprague-Dawley; Spleen; T-Lymphocytes, Regulatory; Trinitrobenzenesulfonic Acid	2017
Interleukin-27 Is a Potential Rescue Therapy for Acute Severe Colitis Through Interleukin-10-Dependent, T-Cell-Independent Attenuation of Colonic Mucosal Innate Immune Responses. Inflammatory bowel diseases, 2017, Volume: 23, Issue:11 Topics: Acute Disease; Animals; Colitis; Colon; Disease Models, Animal; Immunity, Innate; Inflammation; Inflammatory Bowel Diseases; Interleukin-10; Interleukin-27; Intestinal Mucosa; Male; Mice; Mice, Knockout; T-Lymphocytes; Trinitrobenzenesulfonic Acid	2017
Bacteriocin biosynthesis contributes to the anti-inflammatory capacities of probiotic Lactobacillus plantarum. Beneficial microbes, 2018, Feb-27, Volume: 9, Issue:2 Topics: Animals; Anti-Inflammatory Agents; Bacteria; Bacteriocins; Cecum; Colitis; Colon; Disease Models, Animal; DNA, Bacterial; Feces; Gastrointestinal Microbiome; Gene Deletion; Inflammatory Bowel Diseases; Interleukin-6; Lactobacillus plantarum; Mice; Probiotics; RNA, Ribosomal, 16S; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha	2018
Bifidobacteria alleviate experimentally induced colitis by upregulating indoleamine 2, 3-dioxygenase expression. Microbiology and immunology, 2018, Volume: 62, Issue:2 Topics: Animals; Bifidobacterium; Colitis; Colonic Diseases; Disease Models, Animal; Female; Forkhead Transcription Factors; Indoleamine-Pyrrole 2,3,-Dioxygenase; Inflammatory Bowel Diseases; Interleukin-17; Mice; Mice, Inbred BALB C; Probiotics; T-Lymphocytes, Regulatory; Trinitrobenzenesulfonic Acid; Tryptophan; Up-Regulation	2018
Aronia melanocarpa fruit juice ameliorates the symptoms of inflammatory bowel disease in TNBS-induced colitis in rats. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2018, Volume: 113 Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Colitis; Disease Models, Animal; Fruit and Vegetable Juices; Inflammatory Bowel Diseases; Male; Photinia; Plant Extracts; Rats; Rats, Wistar; Sulfasalazine; Thiobarbituric Acid Reactive Substances; Trinitrobenzenesulfonic Acid	2018
New probiotic strains for inflammatory bowel disease management identified by combining in vitro and in vivo approaches. Beneficial microbes, 2018, Feb-27, Volume: 9, Issue:2 Topics: Animals; Anti-Inflammatory Agents; Bifidobacterium; Caco-2 Cells; Cells, Cultured; Colitis; Cytokines; Disease Models, Animal; Humans; Hydrogen Peroxide; Immunomodulation; Inflammatory Bowel Diseases; Intestinal Mucosa; Lactobacillus; Mice; Mice, Inbred BALB C; Permeability; Probiotics; Trinitrobenzenesulfonic Acid	2018
Pim-1 inhibitor attenuates trinitrobenzene sulphonic acid induced colitis in the mice. Clinics and research in hepatology and gastroenterology, 2018, Volume: 42, Issue:4 Topics: Animals; Cell Differentiation; Colitis; Colon; Disease Models, Animal; Forkhead Transcription Factors; GATA3 Transcription Factor; Inflammatory Bowel Diseases; Mice, Inbred BALB C; Nuclear Receptor Subfamily 1, Group F, Member 3; Proto-Oncogene Proteins c-pim-1; RNA, Messenger; T-Lymphocytes; T-Lymphocytes, Regulatory; Trinitrobenzenesulfonic Acid	2018
Comparison of two models of inflammatory bowel disease in rats. Advances in clinical and experimental medicine : official organ Wroclaw Medical University, 2018, Volume: 27, Issue:5 Topics: Animals; Colitis; Dextran Sulfate; Disease Models, Animal; Humans; Inflammatory Bowel Diseases; Oxidative Stress; Rats; Trinitrobenzenesulfonic Acid	2018
BLT1 in dendritic cells promotes Th1/Th17 differentiation and its deficiency ameliorates TNBS-induced colitis. Cellular & molecular immunology, 2018, Volume: 15, Issue:12 Topics: Animals; Cell Differentiation; Cells, Cultured; Colitis; Colon; Cytokines; Dendritic Cells; Disease Models, Animal; Humans; Inflammation Mediators; Inflammatory Bowel Diseases; Leukotriene B4; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptors, Leukotriene B4; Signal Transduction; Th1 Cells; Th17 Cells; Trinitrobenzenesulfonic Acid	2018
Smart gated magnetic silica mesoporous particles for targeted colon drug delivery: New approaches for inflammatory bowel diseases treatment. Journal of controlled release : official journal of the Controlled Release Society, 2018, 07-10, Volume: 281 Topics: Animals; Colitis; Colon; Drug Carriers; Drug Liberation; Humans; Inflammatory Bowel Diseases; Magnetics; Magnetite Nanoparticles; Male; Oleic Acid; Particle Size; Phenazines; Porosity; Rats, Wistar; Silicon Dioxide; Surface Properties; Trinitrobenzenesulfonic Acid	2018
[Effects of Pim-1 inhibitor on mouse model of inflammatory bowel disease induced by TNBS]. Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2018, May-28, Volume: 43, Issue:5 Topics: Animals; Anti-Inflammatory Agents; Cell Differentiation; Colitis; Colon; Ethanol; Forkhead Transcription Factors; GATA3 Transcription Factor; Inflammatory Bowel Diseases; Mice; Mice, Inbred BALB C; Nuclear Receptor Subfamily 1, Group F, Member 3; Prednisolone; Proto-Oncogene Proteins c-pim-1; Random Allocation; T-Box Domain Proteins; T-Lymphocytes, Regulatory; Trinitrobenzenesulfonic Acid	2018
Synthesis and biological evaluation of pyridine-linked indanone derivatives: Potential agents for inflammatory bowel disease. Bioorganic & medicinal chemistry letters, 2018, 08-01, Volume: 28, Issue:14 Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Adhesion; Colitis; Disease Models, Animal; Dose-Response Relationship, Drug; Epithelial Cells; HT29 Cells; Humans; Indans; Inflammatory Bowel Diseases; Molecular Structure; Monocytes; Pyridines; Rats; Structure-Activity Relationship; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha	2018
Therapeutic effects of kefir grain Lactobacillus-derived extracellular vesicles in mice with 2,4,6-trinitrobenzene sulfonic acid-induced inflammatory bowel disease. Journal of dairy science, 2018, Volume: 101, Issue:10 Topics: Animals; Caco-2 Cells; Extracellular Vesicles; Humans; Inflammatory Bowel Diseases; Kefir; Lactobacillus; Mice; Trinitrobenzenes; Trinitrobenzenesulfonic Acid	2018
Mucus-penetrating budesonide nanosuspension enema for local treatment of inflammatory bowel disease. Biomaterials, 2018, Volume: 185 Topics: Animals; Anti-Inflammatory Agents; Budesonide; Colon; Drug Compounding; Drug Delivery Systems; Enema; Inflammatory Bowel Diseases; Male; Mice; Mice, Inbred C57BL; Mucus; Nanoparticles; Poloxamer; Polystyrenes; Suspensions; Trinitrobenzenesulfonic Acid	2018
NOX1-derived ROS drive the expression of Lipocalin-2 in colonic epithelial cells in inflammatory conditions. Mucosal immunology, 2019, Volume: 12, Issue:1 Topics: Animals; Cells, Cultured; Colitis; Colon; Cytochrome b Group; Cytokines; Gene Expression Regulation; Humans; Immunity, Innate; Inflammatory Bowel Diseases; Interleukin-17; Intestinal Mucosa; Lipocalin-2; Mice; Mice, Knockout; NADPH Oxidase 1; NADPH Oxidases; p38 Mitogen-Activated Protein Kinases; Reactive Oxygen Species; RNA, Small Interfering; Signal Transduction; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha	2019
Non-toxigenic Bacteroides fragilis (NTBF) administration reduces bacteria-driven chronic colitis and tumor development independent of polysaccharide A. Mucosal immunology, 2019, Volume: 12, Issue:1 Topics: Adenomatous Polyposis Coli Protein; Animals; Bacteroides fragilis; Carcinogenesis; Cells, Cultured; Colitis; Colorectal Neoplasms; Disease Models, Animal; Humans; Inflammatory Bowel Diseases; Interleukin-17; Intestinal Mucosa; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Mice, Knockout; Th17 Cells; Trinitrobenzenesulfonic Acid	2019
A moderately elevated soy protein diet mitigates inflammatory changes in gut and in bone turnover during chronic TNBS-induced inflammatory bowel disease. Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme, 2019, Volume: 44, Issue:6 Topics: Animals; Bone Remodeling; Colon; Cytokines; Diet; Inflammation; Inflammatory Bowel Diseases; Male; Membrane Glycoproteins; RANK Ligand; Rats, Sprague-Dawley; Soybean Proteins; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha	2019
The protective effects of Poria cocos-derived polysaccharide CMP33 against IBD in mice and its molecular mechanism. Food & function, 2018, Nov-14, Volume: 9, Issue:11 Topics: Animals; Chromatography, High Pressure Liquid; Colon; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Fatty Acid-Binding Proteins; Haptoglobins; Hydroxymethylglutaryl-CoA Synthase; Inflammatory Bowel Diseases; Male; Malondialdehyde; Metabolomics; Mice; N-Acetylgalactosaminyltransferases; Peroxidase; Polysaccharides; Proteomics; Sulfasalazine; Tandem Mass Spectrometry; Trinitrobenzenesulfonic Acid; Wolfiporia	2018
Effect of Trichinella spiralis intervention on TNBS-induced experimental colitis in mice. Immunobiology, 2019, Volume: 224, Issue:1 Topics: Animals; Colitis; Colon; Disease Models, Animal; Forkhead Transcription Factors; Humans; Inflammatory Bowel Diseases; Interferon-gamma; Interleukin-4; Male; Mice; Mice, Inbred BALB C; T-Lymphocytes, Regulatory; Th2 Cells; Therapy with Helminths; Trichinella spiralis; Trichinellosis; Trinitrobenzenesulfonic Acid	2019
Effect of recombinant Trichinella spiralis cysteine proteinase inhibitor on TNBS-induced experimental inflammatory bowel disease in mice. International immunopharmacology, 2019, Volume: 66 Topics: Animals; Cells, Cultured; Colitis; Colon; Cysteine Proteinase Inhibitors; Disease Models, Animal; Humans; Immunomodulation; Inflammatory Bowel Diseases; Male; Mice; Mice, Inbred BALB C; T-Lymphocytes, Regulatory; Th1 Cells; Th1-Th2 Balance; Th2 Cells; Trichinella spiralis; Trinitrobenzenesulfonic Acid	2019
Total Glycosides of Peony Protects Against Inflammatory Bowel Disease by Regulating IL-23/IL-17 Axis and Th17/Treg Balance. The American journal of Chinese medicine, 2019, Volume: 47, Issue:1 Topics: Animals; Colitis; Disease Models, Animal; Glycosides; Inflammatory Bowel Diseases; Interleukin-17; Interleukin-23; Male; Mice, Inbred BALB C; Paeonia; Phytotherapy; Specific Pathogen-Free Organisms; T-Lymphocytes, Regulatory; Th17 Cells; Trinitrobenzenesulfonic Acid	2019
Comparative Efficacy of Chitosan, Pectin Based Mesalamine Colon Targeted Drug Delivery Systems on TNBS-induced IBD Model Rats. Anti-inflammatory & anti-allergy agents in medicinal chemistry, 2020, Volume: 19, Issue:2 Topics: Animals; Anti-Inflammatory Agents; Chitosan; Colon; Disease Models, Animal; Drug Delivery Systems; Humans; Inflammatory Bowel Diseases; Mesalamine; Pectins; Rats; Rats, Wistar; Reactive Oxygen Species; Trinitrobenzenesulfonic Acid; Ulcer	2020
Divergent Effectiveness of Multispecies Probiotic Preparations on Intestinal Microbiota Structure Depends on Metabolic Properties. Nutrients, 2019, Feb-02, Volume: 11, Issue:2 Topics: Animals; Bacteria; Colitis; Colon; Dextran Sulfate; Disease Models, Animal; Fatty Acids, Volatile; Gastrointestinal Microbiome; Inflammation; Inflammatory Bowel Diseases; Interleukin-10; Intestinal Mucosa; Macrophages; Male; Mice, Inbred BALB C; Probiotics; Species Specificity; T-Lymphocytes, Regulatory; Trinitrobenzenesulfonic Acid	2019
Dendritic cells treated by Trichinella spiralis muscle larval excretory/secretory products alleviate TNBS-induced colitis in mice. International immunopharmacology, 2019, Volume: 70 Topics: Animals; Antigens, Helminth; Colitis; Cytokines; Dendritic Cells; Disease Models, Animal; Female; Helminth Proteins; Humans; Immunotherapy; Inflammatory Bowel Diseases; Lymphocyte Activation; Mice; Mice, Inbred BALB C; T-Lymphocytes, Regulatory; Th2 Cells; Therapy with Helminths; Trichinella spiralis; Trinitrobenzenesulfonic Acid	2019
Ultrastructural changes in colonic epithelial cells in a rat model of inflammatory bowel disease. Microscopy research and technique, 2019, Volume: 82, Issue:8 Topics: Animals; Colon; Disease Models, Animal; Endoplasmic Reticulum; Epithelial Cells; Goblet Cells; Golgi Apparatus; Inflammatory Bowel Diseases; Male; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Mucins; Rats; Trinitrobenzenesulfonic Acid	2019
EZH2 Regulates Intestinal Inflammation and Necroptosis Through the JNK Signaling Pathway in Intestinal Epithelial Cells. Digestive diseases and sciences, 2019, Volume: 64, Issue:12 Topics: Animals; Caco-2 Cells; Chemokine CCL20; Chemokine CCL5; Colitis; Colitis, Ulcerative; Crohn Disease; Dextran Sulfate; Down-Regulation; Enhancer of Zeste Homolog 2 Protein; Gene Knockdown Techniques; Humans; In Vitro Techniques; Inflammation; Inflammatory Bowel Diseases; Interleukin-17; Interleukin-8; Intestinal Mucosa; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Mice; Necroptosis; Nuclear Pore Complex Proteins; Phosphoproteins; Proto-Oncogene Proteins c-jun; Real-Time Polymerase Chain Reaction; Receptor-Interacting Protein Serine-Threonine Kinases; RNA-Binding Proteins; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha	2019
Dihydroartemisinin Regulates the Th/Treg Balance by Inducing Activated CD4+ T cell Apoptosis via Heme Oxygenase-1 Induction in Mouse Models of Inflammatory Bowel Disease. Molecules (Basel, Switzerland), 2019, Jul-05, Volume: 24, Issue:13 Topics: Animals; Apoptosis; Artemisinins; Colitis; Disease Models, Animal; Enzyme Induction; Heme Oxygenase-1; Inflammatory Bowel Diseases; Lymphocyte Activation; Lymphocyte Subsets; Mice; Oxazolone; T-Lymphocytes, Helper-Inducer; T-Lymphocytes, Regulatory; Trinitrobenzenesulfonic Acid	2019
Sacral nerve stimulation improves colonic inflammation mediated by autonomic-inflammatory cytokine mechanism in rats. Neurogastroenterology and motility, 2019, Volume: 31, Issue:10 Topics: Animals; Autonomic Nervous System; Colitis; Colon; Cytokines; Dextran Sulfate; Disease Models, Animal; Electric Stimulation Therapy; Inflammation; Inflammatory Bowel Diseases; Lumbosacral Plexus; Rats; Trinitrobenzenesulfonic Acid; Vagus Nerve Stimulation	2019
Chemically induced intestinal damage models in zebrafish larvae. Zebrafish, 2013, Volume: 10, Issue:2 Topics: Alcian Blue; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Dextran Sulfate; Disease Models, Animal; Drug Discovery; Enterocolitis; Flow Cytometry; Humans; Immersion; Inflammation; Inflammatory Bowel Diseases; Interleukin-23; Intestines; Larva; Microinjections; Morpholinos; Neutral Red; Neutrophils; Nitric Oxide; Optical Imaging; Polymerase Chain Reaction; Trinitrobenzenesulfonic Acid; Zebrafish; Zebrafish Proteins	2013
The stimulatory adenosine receptor ADORA2B regulates serotonin (5-HT) synthesis and release in oxygen-depleted EC cells in inflammatory bowel disease. PloS one, 2013, Volume: 8, Issue:4 Topics: Adenosine; Adult; Aged; Animals; Cell Hypoxia; Colitis; Disease Models, Animal; Enterochromaffin Cells; Female; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Inflammatory Bowel Diseases; Intestinal Mucosa; Male; Middle Aged; Oxygen; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2B; Response Elements; RNA, Messenger; Serotonin; Signal Transduction; Trinitrobenzenesulfonic Acid	2013
Serum calprotectin levels correlate with biochemical and histological markers of disease activity in TNBS colitis. Cellular immunology, 2013, Volume: 282, Issue:1 Topics: Animals; Biomarkers; Colitis; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Feces; Humans; Inflammatory Bowel Diseases; Interleukin-6; Leukocyte L1 Antigen Complex; Male; Rats; Rats, Wistar; Time Factors; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha; Weight Loss	2013
Intestinal epithelial vitamin D receptor signaling inhibits experimental colitis. The Journal of clinical investigation, 2013, Volume: 123, Issue:9 Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Colitis; Colon; Dextran Sulfate; Epithelial Cells; HCT116 Cells; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Mice; Mice, Inbred C57BL; Mice, Transgenic; NF-kappa B; Receptors, Calcitriol; Signal Transduction; Tight Junctions; Transcriptional Activation; Trinitrobenzenesulfonic Acid; Tumor Suppressor Proteins	2013
Design and development of novel azo prodrugs using various permutations and combinations of 5- and 4-aminosalicylic acids for inflammatory bowel disease: a colon-targeted approach. Inflammation & allergy drug targets, 2013, Volume: 12, Issue:5 Topics: Aminosalicylic Acid; Animals; Azo Compounds; Colitis; Colon; Drug Design; Female; Humans; Inflammatory Bowel Diseases; Male; Mesalamine; Models, Animal; Prodrugs; Rats; Rats, Wistar; Sulfasalazine; Trinitrobenzenesulfonic Acid	2013
Aluminum enhances inflammation and decreases mucosal healing in experimental colitis in mice. Mucosal immunology, 2014, Volume: 7, Issue:3 Topics: Aluminum; Aluminum Compounds; Animals; Cell Line; Chronic Disease; Colitis; Cytokines; Disease Models, Animal; Gene Expression Regulation; Granuloma; Humans; Inflammation Mediators; Inflammatory Bowel Diseases; Interleukin-10; Intestinal Mucosa; Male; Mice; Mice, Knockout; Phosphates; Trinitrobenzenesulfonic Acid; Wound Healing	2014
Comparative evaluation of different doses of PPAR-γ agonist alone and in combination with sulfasalazine in experimentally induced inflammatory bowel disease in rats. Pharmacological reports : PR, 2013, Volume: 65, Issue:4 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Inflammatory Bowel Diseases; Intestinal Mucosa; Male; Malondialdehyde; Peroxidase; Pioglitazone; PPAR gamma; Rats; Sulfasalazine; Thiazolidinediones; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha	2013
Comparison of experimental mouse models of inflammatory bowel disease. International journal of molecular medicine, 2014, Volume: 33, Issue:2 Topics: Acute Disease; Animals; Caspase 1; Chronic Disease; Colitis; Dextran Sulfate; Disease Models, Animal; Inflammatory Bowel Diseases; Interleukin-4; Mice; Mice, Inbred C57BL; Mice, Knockout; T-Lymphocytes; Trinitrobenzenesulfonic Acid	2014
Effects of interleukin-4 or interleukin-10 gene therapy on trinitrobenzenesulfonic acid-induced murine colitis. BMC gastroenterology, 2013, Dec-06, Volume: 13 Topics: Animals; Colitis; Colon; Disease Models, Animal; Genetic Therapy; Inflammatory Bowel Diseases; Interferon-gamma; Interleukin-10; Interleukin-4; Interleukin-6; Mice; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha	2013
Anti-inflammatory and antinociceptive action of an orally available nociceptin receptor agonist SCH 221510 in a mouse model of inflammatory bowel diseases. The Journal of pharmacology and experimental therapeutics, 2014, Volume: 348, Issue:3 Topics: Abdominal Pain; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Animals; Anti-Inflammatory Agents, Non-Steroidal; Azabicyclo Compounds; Case-Control Studies; Colitis, Ulcerative; Colon; Female; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Male; Mice; Mice, Inbred BALB C; Middle Aged; Mustard Plant; Nociceptin Receptor; Plant Oils; Receptors, Opioid; Trinitrobenzenesulfonic Acid; Young Adult	2014
A 3-D artificial colon tissue mimic for the evaluation of nanoparticle-based drug delivery system. Molecular pharmaceutics, 2014, Jul-07, Volume: 11, Issue:7 Topics: Animals; Biomimetics; Caco-2 Cells; Colitis; Colon; Cytokines; Drug Delivery Systems; Drug Evaluation; Extracellular Matrix; Female; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Leukocytes; Mice; Mice, Inbred BALB C; Mucus; Nanoparticles; Trinitrobenzenesulfonic Acid	2014
DNBS/TNBS colitis models: providing insights into inflammatory bowel disease and effects of dietary fat. Journal of visualized experiments : JoVE, 2014, Feb-27, Issue:84 Topics: Animals; Colitis; Dietary Fats; Dinitrofluorobenzene; Disease Models, Animal; Female; Inflammatory Bowel Diseases; Male; Mice; Mice, Inbred C57BL; Rats; Rats, Sprague-Dawley; Trinitrobenzenesulfonic Acid	2014
Role of gut microbiota in a zebrafish model with chemically induced enterocolitis involving toll-like receptor signaling pathways. Zebrafish, 2014, Volume: 11, Issue:3 Topics: Animals; Disease Models, Animal; Enterocolitis; Gastrointestinal Tract; Inflammatory Bowel Diseases; Microbiota; Signal Transduction; Toll-Like Receptors; Trinitrobenzenesulfonic Acid; Zebrafish; Zebrafish Proteins	2014
Telmisartan attenuates colon inflammation, oxidative perturbations and apoptosis in a rat model of experimental inflammatory bowel disease. PloS one, 2014, Volume: 9, Issue:5 Topics: Angiotensin II Type 2 Receptor Blockers; Animals; Antioxidants; Apoptosis; Benzimidazoles; Benzoates; Colitis; Colon; Disease Models, Animal; Glutathione; Glutathione Peroxidase; Immunohistochemistry; Inflammation; Inflammatory Bowel Diseases; Lipid Peroxidation; Male; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Oxidative Stress; Rats; Rats, Wistar; RNA, Messenger; Superoxide Dismutase; Telmisartan; Trinitrobenzenesulfonic Acid	2014
Thrombin mediates vagal apoptosis and dysfunction in inflammatory bowel disease. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 2014, Volume: 18, Issue:8 Topics: Animals; Apoptosis; Biomarkers; Brain Stem; Colitis, Ulcerative; Fluorescent Antibody Technique; In Situ Nick-End Labeling; Inflammatory Bowel Diseases; Male; Neurons; Prothrombin; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Thrombin; Trinitrobenzenesulfonic Acid; Vagus Nerve	2014
Efficacy of thalidomide on trinitrobenzene sulfonate-induced colitis in young rats and its mechanism. Chinese medical journal, 2014, Volume: 127, Issue:12 Topics: Animals; Colitis; Cytokines; Inflammatory Bowel Diseases; Interleukin-10; Interleukin-1beta; NF-kappa B; Rats; Rats, Sprague-Dawley; Thalidomide; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha	2014
TNFα causes thrombin-dependent vagal neuron apoptosis in inflammatory bowel disease. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 2014, Volume: 18, Issue:9 Topics: Animals; Apoptosis; Caspase 3; CD11b Antigen; Inflammatory Bowel Diseases; Male; Microglia; Neurons, Efferent; Prothrombin; Rats; Rats, Sprague-Dawley; Receptor, PAR-1; Receptors, Tumor Necrosis Factor, Type I; RNA, Messenger; Thrombin; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha; Vagus Nerve	2014
In vivo evaluation of inflammatory bowel disease with the aid of μPET and the translocator protein 18 kDa radioligand [18F]DPA-714. Molecular imaging and biology, 2015, Volume: 17, Issue:1 Topics: Animals; Colon; Dextran Sulfate; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gamma Rays; Glucose; Image Processing, Computer-Assisted; Immunohistochemistry; Inflammation; Inflammatory Bowel Diseases; Ligands; Male; Positron-Emission Tomography; Pyrazoles; Pyrimidines; Rats; Rats, Wistar; Trinitrobenzenesulfonic Acid	2015
Anti-inflammatory and antinociceptive action of the dimeric enkephalin peptide biphalin in the mouse model of colitis: new potential treatment of abdominal pain associated with inflammatory bowel diseases. Peptides, 2014, Volume: 60 Topics: Abdominal Pain; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Colitis; Disease Models, Animal; Enkephalins; Inflammation; Inflammatory Bowel Diseases; Injections, Intraperitoneal; Injections, Intraventricular; Male; Mice; Mice, Inbred BALB C; Mustard Plant; Plant Oils; Trinitrobenzenesulfonic Acid	2014
MicroRNA 29 targets nuclear factor-κB-repressing factor and Claudin 1 to increase intestinal permeability. Gastroenterology, 2015, Volume: 148, Issue:1 Topics: Animals; Case-Control Studies; Cell Line; Claudin-1; Colitis; Colon; Disease Models, Animal; Down-Regulation; Gene Knockdown Techniques; Genetic Predisposition to Disease; Humans; Inflammatory Bowel Diseases; Male; Mice, Inbred C57BL; Mice, Knockout; MicroRNAs; Permeability; Phenotype; Repressor Proteins; RNA, Messenger; Signal Transduction; Trinitrobenzenesulfonic Acid	2015
The neurotensin-HIF-1α-VEGFα axis orchestrates hypoxia, colonic inflammation, and intestinal angiogenesis. The American journal of pathology, 2014, Volume: 184, Issue:12 Topics: Animals; Colitis; Colon; Disease Models, Animal; Endothelial Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Inflammation; Inflammatory Bowel Diseases; Intestinal Mucosa; Intestines; Male; Mice; Microcirculation; Neovascularization, Pathologic; Receptors, Neurotensin; Trinitrobenzenesulfonic Acid; Up-Regulation; Vascular Endothelial Growth Factor A	2014
Ly49E expression on CD8αα-expressing intestinal intraepithelial lymphocytes plays no detectable role in the development and progression of experimentally induced inflammatory bowel diseases. PloS one, 2014, Volume: 9, Issue:10 Topics: Animals; CD8 Antigens; Cell Count; Colitis; Colon; Dextran Sulfate; Disease Progression; Epithelial Cells; Ileitis; Inflammatory Bowel Diseases; Intestines; Lymphocytes; Mice, Inbred C57BL; Mice, Knockout; NK Cell Lectin-Like Receptor Subfamily A; Receptors, Natural Killer Cell; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha	2014
A diet with lactosucrose supplementation ameliorates trinitrobenzene sulfonic acid-induced colitis in rats. Food & function, 2015, Volume: 6, Issue:1 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Colitis; Colon; Disease Models, Animal; Female; Gastrointestinal Agents; Inflammatory Bowel Diseases; Interleukin-10; Interleukin-12; Intestinal Mucosa; Prebiotics; Random Allocation; Rats, Sprague-Dawley; Specific Pathogen-Free Organisms; Sulfasalazine; Toll-Like Receptor 2; Transcription Factor RelA; Trinitrobenzenesulfonic Acid; Trisaccharides	2015
PGRN protects against colitis progression in mice in an IL-10 and TNFR2 dependent manner. Scientific reports, 2014, Nov-12, Volume: 4 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bone Marrow; CD4-Positive T-Lymphocytes; Dextran Sulfate; Disease Models, Animal; Disease Progression; Gene Expression Regulation; Granulins; Humans; Inflammatory Bowel Diseases; Intercellular Signaling Peptides and Proteins; Interleukin-10; Mice; Mice, Knockout; Progranulins; Receptors, Tumor Necrosis Factor, Type II; Recombinant Proteins; Signal Transduction; Transplantation Chimera; Trinitrobenzenesulfonic Acid	2014
Electroacupuncture ameliorates experimental colitis induced by TNBS through activation of interleukin-10 and inhibition of iNOS in mice. Acta cirurgica brasileira, 2014, Volume: 29, Issue:12 Topics: Acupuncture Points; Animals; Anti-Inflammatory Agents; Colitis; Colon; Disease Models, Animal; Electroacupuncture; Immunohistochemistry; Inflammatory Bowel Diseases; Interleukin-10; Interleukin-1beta; Male; Malondialdehyde; Mice; Nitric Oxide Synthase Type II; Peroxidase; Random Allocation; Trinitrobenzenesulfonic Acid	2014
Zeyheria montana Mart. (Bignoniaceae) as source of antioxidant and immunomodulatory compounds with beneficial effects on intestinal inflammation. The Journal of pharmacy and pharmacology, 2015, Volume: 67, Issue:4 Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Bignoniaceae; Brazil; Colitis; Flavonoids; Immunologic Factors; Inflammation; Inflammatory Bowel Diseases; Intestines; Lipid Peroxidation; Male; Mice, Inbred BALB C; Phytotherapy; Plant Extracts; Plant Leaves; Trinitrobenzenesulfonic Acid	2015
Prostaglandin E₂ and polyenylphosphatidylcholine protect against intestinal fibrosis and regulate myofibroblast function. Digestive diseases and sciences, 2015, Volume: 60, Issue:6 Topics: Animals; Biomarkers; Cytokines; Dinoprostone; Disease Models, Animal; Female; Fibrosis; Gene Expression; Humans; Immunoenzyme Techniques; Inflammatory Bowel Diseases; Mice; Mice, Inbred C57BL; Myofibroblasts; Phosphatidylcholines; Real-Time Polymerase Chain Reaction; Trinitrobenzenesulfonic Acid	2015
Intestinal anti-inflammatory activity of apigenin K in two rat colitis models induced by trinitrobenzenesulfonic acid and dextran sulphate sodium. The British journal of nutrition, 2015, Feb-28, Volume: 113, Issue:4 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apigenin; Biomarkers; Colitis; Colon; Dextran Sulfate; Dietary Supplements; Disease Models, Animal; Female; Gastrointestinal Agents; Inflammation Mediators; Inflammatory Bowel Diseases; Intestinal Mucosa; Organ Size; Pilot Projects; Random Allocation; Rats, Wistar; Solubility; Trinitrobenzenesulfonic Acid	2015
[Experimental study of adipose-derived mesenchymal stem cells in the treatment of Crohn's disease]. Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery, 2015, Volume: 18, Issue:1 Topics: Adipocytes; Animals; Colitis; Crohn Disease; Cytokines; Disease Models, Animal; Down-Regulation; Female; Inflammatory Bowel Diseases; Mesenchymal Stem Cells; Mice; Mice, Inbred BALB C; Trinitrobenzenesulfonic Acid; Up-Regulation	2015
Recombinant human MFG-E8 ameliorates colon damage in DSS- and TNBS-induced colitis in mice. Laboratory investigation; a journal of technical methods and pathology, 2015, Volume: 95, Issue:5 Topics: Animals; Antigens, Surface; Apoptosis; Cell Line; Colitis; Colon; Cytokines; Dextran Sulfate; Disease Models, Animal; Humans; Inflammatory Bowel Diseases; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Milk Proteins; Protective Agents; Recombinant Proteins; Trinitrobenzenesulfonic Acid	2015
Vitamin D/VDR signaling pathway ameliorates 2,4,6-trinitrobenzene sulfonic acid-induced colitis by inhibiting intestinal epithelial apoptosis. International journal of molecular medicine, 2015, Volume: 35, Issue:5 Topics: Animals; Apoptosis; Case-Control Studies; Colitis; Cytokines; Disease Models, Animal; Gene Expression Regulation; Humans; Inflammation Mediators; Inflammatory Bowel Diseases; Intestinal Mucosa; Male; Mice; Permeability; Receptors, Calcitriol; Signal Transduction; Trinitrobenzenesulfonic Acid; Vitamin D	2015
Catecholamine Mediates Psychological Stress-Induced Colitis Through a2-Adrenoreceptor. Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research, 2015, Volume: 35, Issue:7 Topics: Animals; Catecholamines; Colitis; Dopamine beta-Hydroxylase; Humans; Inflammatory Bowel Diseases; Male; Mice, Inbred BALB C; Receptors, Adrenergic, alpha-2; Stress, Psychological; Trinitrobenzenesulfonic Acid	2015
St. John's wort may ameliorate 2,4,6-trinitrobenzenesulfonic acid colitis off rats through the induction of pregnane X receptors and/or P-glycoproteins. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2015, Volume: 66, Issue:2 Topics: Animals; Anti-Inflammatory Agents; Antioxidants; ATP Binding Cassette Transporter, Subfamily B; Colitis, Ulcerative; Cytochrome P-450 Enzyme System; Hypericum; Inflammatory Bowel Diseases; Male; NF-kappa B; Oxidative Stress; Peroxidase; Plant Extracts; Pregnane X Receptor; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Steroid; Spironolactone; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha	2015
Resveratrol Pretreatment Ameliorates TNBS Colitis in Rats. Recent patents on endocrine, metabolic & immune drug discovery, 2015, Volume: 9, Issue:2 Topics: Animals; Antioxidants; Colitis; Female; Inflammatory Bowel Diseases; Oxidative Stress; Peroxidase; Rats; Rats, Wistar; Resveratrol; Stilbenes; Superoxide Dismutase; Trinitrobenzenesulfonic Acid	2015
Experimental evidence of heparanase, Hsp70 and NF-κB gene expression on the response of anti-inflammatory drugs in TNBS-induced colonic inflammation. Life sciences, 2015, Nov-15, Volume: 141 Topics: Animals; Anti-Inflammatory Agents; Azathioprine; Biomarkers; Colitis; Colon; Cytokines; Gene Expression; Glucuronidase; HSP70 Heat-Shock Proteins; Inflammatory Bowel Diseases; Male; NF-kappa B; Prednisolone; Rats; Rats, Wistar; Sulfasalazine; Trinitrobenzenesulfonic Acid	2015
The activation of Wnt signaling by a STAT6-dependent macrophage phenotype promotes mucosal repair in murine IBD. Mucosal immunology, 2016, Volume: 9, Issue:4 Topics: Animals; Cell Differentiation; Cells, Cultured; Colitis; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; Mice, Knockout; Phenotype; Signal Transduction; STAT6 Transcription Factor; Trinitrobenzenesulfonic Acid; Wnt Proteins; Wound Healing	2016
Histological and immunohistochemical effects of L-arginine and silymarin on TNBS-induced inflammatory bowel disease in rats. Histology and histopathology, 2016, Volume: 31, Issue:11 Topics: Animals; Antioxidants; Arginine; Disease Models, Animal; Immunohistochemistry; Inflammatory Bowel Diseases; Male; Random Allocation; Rats; Silymarin; Trinitrobenzenesulfonic Acid	2016
Ozanimod (RPC1063) is a potent sphingosine-1-phosphate receptor-1 (S1P1 ) and receptor-5 (S1P5 ) agonist with autoimmune disease-modifying activity. British journal of pharmacology, 2016, Volume: 173, Issue:11 Topics: Animals; Autoimmune Diseases; Disease Models, Animal; Female; Indans; Inflammatory Bowel Diseases; Male; Mice; Mice, Inbred C57BL; Mice, SCID; Myelin-Oligodendrocyte Glycoprotein; Oxadiazoles; Rats; Rats, Sprague-Dawley; Receptors, Lysosphingolipid; Trinitrobenzenesulfonic Acid	2016
Methods of Inducing Inflammatory Bowel Disease in Mice. Current protocols in pharmacology, 2016, Mar-18, Volume: 72 Topics: Animals; Colitis; Dextran Sulfate; Disease Models, Animal; Female; Inflammation; Inflammatory Bowel Diseases; Interleukin-10; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, SCID; Trinitrobenzenes; Trinitrobenzenesulfonic Acid	2016
Pro-inflammatory miR-223 mediates the cross-talk between the IL23 pathway and the intestinal barrier in inflammatory bowel disease. Genome biology, 2016, Mar-30, Volume: 17 Topics: Animals; Antagomirs; Caco-2 Cells; Cell Line; Claudins; Disease Models, Animal; Gene Expression Profiling; Gene Expression Regulation; Humans; Inflammatory Bowel Diseases; Interleukin-23; Mice; MicroRNAs; Oligonucleotide Array Sequence Analysis; Oligonucleotides; Signal Transduction; Trinitrobenzenesulfonic Acid	2016
Effects of AP‑1 and NF‑κB inhibitors on colonic endocrine cells in rats with TNBS‑induced colitis. Molecular medicine reports, 2016, Volume: 14, Issue:2 Topics: Animals; Benzamides; Biomarkers; Body Weight; Chromogranin A; Colitis; Cyclohexanones; Disease Models, Animal; Endocrine Cells; Gene Expression; Inflammatory Bowel Diseases; Intestinal Mucosa; Male; NF-kappa B; Piperidones; Rats; Serotonin; Transcription Factor AP-1; Trinitrobenzenesulfonic Acid	2016
Transplantation of a bacterial consortium ameliorates trinitrobenzenesulfonic acid-induced colitis and intestinal dysbiosis in rats. Future microbiology, 2016, Volume: 11 Topics: Animals; Colitis; Colon; Cytokines; Disease Models, Animal; Dysbiosis; Fecal Microbiota Transplantation; Feces; Gastrointestinal Microbiome; Inflammatory Bowel Diseases; Intestines; Mice; Microbial Consortia; Peroxidase; Rats; Trinitrobenzenesulfonic Acid	2016
Anti-Inflammatory and Anti-Oxidant Effects of p-Chloro-phenyl-selenoesterol on TNBS-Induced Inflammatory Bowel Disease in Mice. Journal of cellular biochemistry, 2017, Volume: 118, Issue:4 Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Cytokines; Disease Models, Animal; Female; Inflammation Mediators; Inflammatory Bowel Diseases; Mice; Organoselenium Compounds; Oxidative Stress; Peroxidase; Trinitrobenzenesulfonic Acid	2017
Journal of tribology, 2016, Volume: 138, Issue:4 Topics: Adalimumab; Anemia; Animals; Anti-Inflammatory Agents; Colon; Disease Models, Animal; Humans; Inflammatory Bowel Diseases; Infliximab; Intestinal Mucosa; Iron; Male; Malondialdehyde; Patient Outcome Assessment; Psychometrics; Rats; Rats, Wistar; Self Report; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha	2016
Investigation of pulmonary involvement in inflammatory bowel disease in an experimental model of colitis. The Korean journal of internal medicine, 2016, Volume: 31, Issue:5 Topics: Animals; Colitis; Dextran Sulfate; Disease Models, Animal; Humans; Inflammatory Bowel Diseases; Lung; Male; Rats; Rats, Wistar; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A	2016
Partially hydrolysed guar gum ameliorates murine intestinal inflammation in association with modulating luminal microbiota and SCFA. The British journal of nutrition, 2016, Volume: 116, Issue:7 Topics: Animals; Colitis; Colon; Disease Models, Animal; Fatty Acids, Volatile; Galactans; Gastrointestinal Microbiome; Hydrolysis; Inflammatory Bowel Diseases; Intestinal Mucosa; Intestines; Male; Mannans; Mice; Mice, Inbred C57BL; Peroxidase; Plant Gums; RNA, Messenger; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha	2016
Colon targeted oral drug delivery system based on alginate-chitosan microspheres loaded with icariin in the treatment of ulcerative colitis. International journal of pharmaceutics, 2016, Dec-30, Volume: 515, Issue:1-2 Topics: Alginates; Animals; Biological Availability; Chitosan; Colitis, Ulcerative; Colon; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Flavonoids; Glucuronic Acid; Hexuronic Acids; Inflammation; Inflammatory Bowel Diseases; Intestinal Mucosa; Male; Microspheres; Rats; Rats, Sprague-Dawley; Solubility; Trinitrobenzenesulfonic Acid	2016
A novel model for studying ileitis-induced visceral hypersensitivity in goats. Acta veterinaria Scandinavica, 2016, Oct-06, Volume: 58, Issue:1 Topics: Animals; Cytokines; Disease Models, Animal; Ethanol; Female; Goat Diseases; Goats; Hypersensitivity; Ileitis; Ileum; Inflammatory Bowel Diseases; Male; Peroxidase; Trinitrobenzenesulfonic Acid; Viscera	2016
Enteroendocrine cells, stem cells and differentiation progenitors in rats with TNBS-induced colitis. International journal of molecular medicine, 2016, Volume: 38, Issue:6 Topics: Animals; Biomarkers; Cell Differentiation; Colitis; Disease Models, Animal; Enteroendocrine Cells; Immunohistochemistry; Inflammatory Bowel Diseases; Male; Rats; Stem Cells; Trinitrobenzenesulfonic Acid	2016
Inflammatory Bowel Disease in a Rodent Model Alters Osteocyte Protein Levels Controlling Bone Turnover. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2017, Volume: 32, Issue:4 Topics: Animals; Bone Morphogenetic Proteins; Bone Remodeling; Cancellous Bone; Cytokines; Disease Models, Animal; Genetic Markers; Inflammatory Bowel Diseases; Male; Osteocytes; Osteoprotegerin; Rats; Rats, Sprague-Dawley; Tibia; Trinitrobenzenesulfonic Acid	2017
High salt diet stimulates gut Th17 response and exacerbates TNBS-induced colitis in mice. Oncotarget, 2017, Jan-03, Volume: 8, Issue:1 Topics: Animals; Colitis; Diet; Disease Models, Animal; Inflammatory Bowel Diseases; Interleukin-17; Intestinal Mucosa; Male; Mice; Mucosal-Associated Invariant T Cells; Sodium, Dietary; T-Lymphocytes, Regulatory; Th1 Cells; Th17 Cells; Trinitrobenzenesulfonic Acid	2017
Astragaloside IV ameliorates 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis implicating regulation of energy metabolism. Scientific reports, 2017, 02-02, Volume: 7 Topics: Actins; Animals; Biomarkers; Cell Count; Colitis; Colon; Disease Models, Animal; Dose-Response Relationship, Drug; Energy Metabolism; Immunohistochemistry; Inflammatory Bowel Diseases; Intestinal Mucosa; Proteolysis; Rats; Regional Blood Flow; Saponins; Stem Cells; Tight Junction Proteins; Trinitrobenzenesulfonic Acid; Triterpenes	2017
Therapeutic efficacy of carboxyamidotriazole on 2,4,6-trinitrobenzene sulfonic acid-induced colitis model is associated with the inhibition of NLRP3 inflammasome and NF-κB activation. International immunopharmacology, 2017, Volume: 45 Topics: Animals; Cells, Cultured; Colitis; Colon; Cytokines; Female; Gene Expression Regulation; Humans; Inflammasomes; Inflammatory Bowel Diseases; Intestines; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Rats; Rats, Sprague-Dawley; Signal Transduction; Triazoles; Trinitrobenzenesulfonic Acid	2017
Therapeutic effect of the immunomodulatory drug lenalidomide, but not pomalidomide, in experimental models of rheumatoid arthritis and inflammatory bowel disease. Experimental & molecular medicine, 2017, 02-03, Volume: 49, Issue:2 Topics: Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Collagen Type II; Dextran Sulfate; Disease Models, Animal; Immunologic Factors; Inflammatory Bowel Diseases; Lenalidomide; Male; Mice; Mice, Inbred C57BL; Thalidomide; Trinitrobenzenesulfonic Acid	2017
Local enema treatment to inhibit FOLH1/GCPII as a novel therapy for inflammatory bowel disease. Journal of controlled release : official journal of the Controlled Release Society, 2017, Oct-10, Volume: 263 Topics: Animals; Colitis; Colon; Enema; Glutamate Carboxypeptidase II; Inflammatory Bowel Diseases; Intestinal Mucosa; Male; Mice, Inbred BALB C; Organophosphorus Compounds; Trinitrobenzenesulfonic Acid	2017
Exploration of Inflammatory Bowel Disease in Mice: Chemically Induced Murine Models of Inflammatory Bowel Disease (IBD). Current protocols in mouse biology, 2017, Mar-02, Volume: 7, Issue:1 Topics: Acute Disease; Animals; Azoxymethane; Cell Transformation, Neoplastic; Chronic Disease; Colitis; Dextran Sulfate; Disease Models, Animal; Humans; Inflammatory Bowel Diseases; Mice; Trinitrobenzenesulfonic Acid	2017
Investigation of mitigating effect of colon-specific prodrugs of boswellic acid on 2,4,6-trinitrobenzene sulfonic acid-induced colitis in Wistar rats: Design, kinetics and biological evaluation. World journal of gastroenterology, 2017, Feb-21, Volume: 23, Issue:7 Topics: Amides; Animals; Colitis; Colon; Drug Delivery Systems; Drug Design; Feces; Inflammatory Bowel Diseases; Kinetics; Male; Prodrugs; Rats; Rats, Wistar; Trinitrobenzenesulfonic Acid; Triterpenes	2017
P2X7 receptor promotes intestinal inflammation in chemically induced colitis and triggers death of mucosal regulatory T cells. Biochimica et biophysica acta. Molecular basis of disease, 2017, Volume: 1863, Issue:6 Topics: Animals; Colitis; Female; Immunity, Mucosal; Inflammation; Inflammatory Bowel Diseases; Intestinal Mucosa; Mice; Mice, Knockout; Oxazolone; Receptors, Purinergic P2X7; T-Lymphocytes; Trinitrobenzenesulfonic Acid	2017
The transcription factor IFN regulatory factor-4 controls experimental colitis in mice via T cell-derived IL-6. The Journal of clinical investigation, 2008, Volume: 118, Issue:7 Topics: Adoptive Transfer; Adult; Animals; Apoptosis; CD4-Positive T-Lymphocytes; Colitis; Cytokines; DNA-Binding Proteins; Female; Gene Expression Regulation; Humans; Inflammatory Bowel Diseases; Interferon Regulatory Factors; Interleukin-6; Intestinal Mucosa; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Oxazolone; Receptors, Interleukin-6; Recombinant Fusion Proteins; T-Lymphocytes; Trinitrobenzenesulfonic Acid	2008
Effect of different doses of thalidomide in experimentally induced inflammatory bowel disease in rats. Basic & clinical pharmacology & toxicology, 2008, Volume: 103, Issue:1 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Disease Models, Animal; Female; Gastrointestinal Agents; Inflammatory Bowel Diseases; Male; Malondialdehyde; Peroxidase; Rats; Rats, Wistar; Sulfasalazine; Thalidomide; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha	2008
Effect of different doses of Manuka honey in experimentally induced inflammatory bowel disease in rats. Phytotherapy research : PTR, 2008, Volume: 22, Issue:11 Topics: Analysis of Variance; Animals; Antioxidants; Colitis; Colon; Disease Models, Animal; Glutathione; Honey; Inflammation; Inflammatory Bowel Diseases; Lipid Peroxidation; Male; Peroxidase; Rats; Rats, Wistar; Sulfasalazine; Superoxide Dismutase; Trinitrobenzenesulfonic Acid	2008
Disturbances in metabolic, transport and structural genes in experimental colonic inflammation in the rat: a longitudinal genomic analysis. BMC genomics, 2008, Oct-17, Volume: 9 Topics: Animals; Cluster Analysis; Colitis; Colon; Disease Models, Animal; Female; Gene Expression Profiling; Genomics; Inflammatory Bowel Diseases; Oligonucleotide Array Sequence Analysis; Rats; Rats, Wistar; Time Factors; Trinitrobenzenesulfonic Acid	2008
pH-Sensitive nanospheres for colon-specific drug delivery in experimentally induced colitis rat model. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2009, Volume: 72, Issue:1 Topics: Animals; Budesonide; Colitis; Colon; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; Hydrogen-Ion Concentration; Inflammatory Bowel Diseases; Nanospheres; Nanotechnology; Polymers; Rats; Tablets, Enteric-Coated; Trinitrobenzenesulfonic Acid	2009
Therapeutic effects of mucosal tolerance on experimental colitis in rats. European journal of gastroenterology & hepatology, 2009, Volume: 21, Issue:10 Topics: Adjuvants, Immunologic; Administration, Intranasal; Administration, Oral; Animals; Antigens; Colitis; Desensitization, Immunologic; Disease Models, Animal; Immune Tolerance; Immunity, Mucosal; Inflammatory Bowel Diseases; Intestinal Mucosa; Lipopolysaccharides; Male; Ovalbumin; Rats; Rats, Sprague-Dawley; T-Lymphocytes, Regulatory; Toll-Like Receptors; Trinitrobenzenesulfonic Acid	2009
FoxO4 inhibits NF-kappaB and protects mice against colonic injury and inflammation. Gastroenterology, 2009, Volume: 137, Issue:4 Topics: Animals; Caco-2 Cells; CD4-Positive T-Lymphocytes; Cell Cycle Proteins; Colitis; Colon; Cytokines; Disease Models, Animal; Forkhead Transcription Factors; Gene Expression Profiling; Humans; Immunity, Mucosal; Inflammatory Bowel Diseases; Mice; Mice, Knockout; NF-kappa B; Permeability; RNA, Messenger; Signal Transduction; Tight Junctions; Time Factors; Transcription Factors; Transcription, Genetic; Transfection; Trinitrobenzenesulfonic Acid; Up-Regulation	2009
Novel immunomodulatory properties of cirsilineol through selective inhibition of IFN-gamma signaling in a murine model of inflammatory bowel disease. Biochemical pharmacology, 2010, Jan-15, Volume: 79, Issue:2 Topics: Animals; Base Sequence; CD4-Positive T-Lymphocytes; Disease Models, Animal; Electrophoretic Mobility Shift Assay; Female; Flavones; Immunologic Factors; Inflammatory Bowel Diseases; Interferon-gamma; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Oligonucleotide Probes; Signal Transduction; Trinitrobenzenesulfonic Acid	2010
Targeted therapy to the IL-2R using diphtheria toxin and caspase-3 fusion proteins modulates Treg and ameliorates inflammatory colitis. European journal of immunology, 2009, Volume: 39, Issue:10 Topics: Animals; Apoptosis; Body Weight; Caspase 3; Cell Proliferation; Colon; Dextran Sulfate; Diphtheria Toxin; Drug Delivery Systems; Forkhead Transcription Factors; Inflammatory Bowel Diseases; Interleukin-2; Lymph Nodes; Male; Mice; Mice, Inbred BALB C; Receptors, Interleukin-2; Recombinant Fusion Proteins; Spleen; Survival Analysis; T-Lymphocyte Subsets; T-Lymphocytes, Regulatory; Trinitrobenzenesulfonic Acid	2009
A model for chronic mucosal inflammation in IBD and periodontitis. Digestive diseases and sciences, 2010, Volume: 55, Issue:8 Topics: Alveolar Bone Loss; Animals; Chronic Disease; Dextran Sulfate; Disease Models, Animal; Inflammation; Inflammatory Bowel Diseases; Intestines; Mice; Periodontitis; Trinitrobenzenesulfonic Acid; Weight Gain	2010
Involvement of T cell Ig Mucin-3 (Tim-3) in the negative regulation of inflammatory bowel disease. Clinical immunology (Orlando, Fla.), 2010, Volume: 134, Issue:2 Topics: Animals; CD4-Positive T-Lymphocytes; Cell Separation; Cytokines; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Hepatitis A Virus Cellular Receptor 2; Inflammatory Bowel Diseases; Mice; Mice, Inbred BALB C; Receptors, Virus; Signal Transduction; T-Lymphocyte Subsets; Trinitrobenzenesulfonic Acid	2010
Effect of COX-2 inhibitor after TNBS-induced colitis in Wistar rats. Journal of molecular histology, 2009, Volume: 40, Issue:4 Topics: Animals; Cyclooxygenase 2 Inhibitors; Diclofenac; Disease Models, Animal; Inflammatory Bowel Diseases; Rats; Rats, Wistar; RNA, Messenger; Trinitrobenzenesulfonic Acid	2009
Grifola frondosa water extract alleviates intestinal inflammation by suppressing TNF-alpha production and its signaling. Experimental & molecular medicine, 2010, Feb-28, Volume: 42, Issue:2 Topics: Animals; Cell Adhesion; Cell Extracts; Chemokine CCL2; Coculture Techniques; Colon; Grifola; HT29 Cells; Humans; Inflammatory Bowel Diseases; Interleukin-8; Intestinal Mucosa; Monocytes; NF-kappa B; Peroxidase; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Stomach Ulcer; Transcription, Genetic; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha; U937 Cells; Weight Loss	2010
CCL2 (pM levels) as a therapeutic agent in Inflammatory Bowel Disease models in mice. Inflammatory bowel diseases, 2010, Volume: 16, Issue:9 Topics: Animals; Azoxymethane; Blotting, Western; Carcinogens; Cell Adhesion; Cell Movement; Cell Proliferation; Chemokine CCL2; Colitis; Colon; Colorectal Neoplasms; Dextran Sulfate; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Immunoenzyme Techniques; Inflammatory Bowel Diseases; Macrophages; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Monocytes; Trinitrobenzenesulfonic Acid	2010
Hematopoietic SCT modulates gut inflammation in experimental inflammatory bowel disease. Bone marrow transplantation, 2010, Volume: 45, Issue:10 Topics: Animals; Bone Marrow Transplantation; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Colitis; Combined Modality Therapy; Cyclosporine; Cytokines; Female; Hematopoietic Stem Cell Transplantation; Immunity, Mucosal; Immunosuppression Therapy; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Mice; Mice, Inbred BALB C; Severity of Illness Index; Survival Analysis; Trinitrobenzenesulfonic Acid	2010
4SC-101, a novel immunosuppressive drug, inhibits IL-17 and attenuates colitis in two murine models of inflammatory bowel disease. Inflammatory bowel diseases, 2010, Volume: 16, Issue:10 Topics: Acute Disease; Animals; Biphenyl Compounds; Blotting, Western; Cell Proliferation; Chronic Disease; Colitis; Dextran Sulfate; Dicarboxylic Acids; Dihydroorotate Dehydrogenase; Disease Models, Animal; Female; Immunoenzyme Techniques; Immunosuppressive Agents; Inflammatory Bowel Diseases; Interleukin-17; Mice; Mice, Inbred BALB C; Oxidoreductases Acting on CH-CH Group Donors; Trinitrobenzenesulfonic Acid	2010
Identification of epithelial to mesenchymal transition as a novel source of fibroblasts in intestinal fibrosis. The Journal of biological chemistry, 2010, Jun-25, Volume: 285, Issue:26 Topics: Animals; beta-Galactosidase; Bone Morphogenetic Protein 7; Cadherins; Cell Line; Cells, Cultured; Colitis; Colon; Epithelial Cells; Female; Fibroblasts; Fibrosis; Humans; Inflammatory Bowel Diseases; Intercellular Signaling Peptides and Proteins; Intestinal Mucosa; Intestines; Lac Operon; Male; Mesoderm; Mice; Mice, Inbred C57BL; Mice, Transgenic; Proteins; Transforming Growth Factor beta1; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha	2010
Expression of interleukin 6 in brain and colon of rats with TNBS-induced colitis. World journal of gastroenterology, 2010, May-14, Volume: 16, Issue:18 Topics: Animals; Base Sequence; Brain; Colitis; Colon; Disease Models, Animal; DNA Primers; Female; Gene Expression; Humans; Inflammatory Bowel Diseases; Interleukin-6; Neuroimmunomodulation; Peroxidase; Rats; Rats, Wistar; RNA, Messenger; Trinitrobenzenesulfonic Acid	2010
Exosomes derived from interleukin-10-treated dendritic cells can inhibit trinitrobenzene sulfonic acid-induced rat colitis. Scandinavian journal of gastroenterology, 2010, Volume: 45, Issue:10 Topics: Animals; Colitis; Dendritic Cells; Disease Models, Animal; Exosomes; Inflammatory Bowel Diseases; Interferon-gamma; Interleukin-10; Interleukin-2; Male; Mucous Membrane; Rats; Rats, Wistar; RNA, Messenger; T-Lymphocytes; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha	2010
Proinflammatory role of vasopressin through V1b receptors in hapten-induced experimental colitis in rodents: implication in IBD. American journal of physiology. Gastrointestinal and liver physiology, 2010, Volume: 299, Issue:6 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Colitis; Gene Expression; Gene Expression Regulation; Haptens; Humans; Indoles; Inflammatory Bowel Diseases; Mice; Phosphodiesterase Inhibitors; Pyrrolidines; Rats; Receptors, Vasopressin; Thioxanthenes; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha; Vasopressins; Water Deprivation; Weight Gain; Xanthones	2010
Adenosine A2A receptors and uric acid mediate protective effects of inosine against TNBS-induced colitis in rats. European journal of pharmacology, 2010, Dec-15, Volume: 649, Issue:1-3 Topics: Adenosine A2 Receptor Antagonists; Animals; Biomarkers; Colitis; Dietary Supplements; Drug Synergism; Enzyme Inhibitors; Inflammation Mediators; Inflammatory Bowel Diseases; Inosine Monophosphate; Lipid Peroxidation; Macrophages; Male; Neutrophil Infiltration; Oxonic Acid; Random Allocation; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Severity of Illness Index; Trinitrobenzenesulfonic Acid; Urate Oxidase; Uric Acid	2010
Beneficial effects of treatment with transglutaminase inhibitor cystamine on the severity of inflammation in a rat model of inflammatory bowel disease. Laboratory investigation; a journal of technical methods and pathology, 2011, Volume: 91, Issue:3 Topics: Adult; Animals; Anti-Inflammatory Agents, Non-Steroidal; Colon; Cystamine; Enzyme Inhibitors; Female; GTP-Binding Proteins; Humans; Inflammatory Bowel Diseases; Interleukin-6; Intestinal Mucosa; Male; Middle Aged; Protein Glutamine gamma Glutamyltransferase 2; Random Allocation; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Transglutaminases; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha	2011
[Pathogenetic mechanism of beta-arrestin1 in experimental colitis of rats and intervention effects of oxymatrine]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 2010, Volume: 30, Issue:10 Topics: Alkaloids; Animals; Arrestins; beta-Arrestins; Colitis; Colon; Inflammatory Bowel Diseases; Male; Proto-Oncogene Proteins c-bcl-2; Quinolizines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Signal Transduction; Trinitrobenzenesulfonic Acid	2010
Comparative evaluation of different doses of green tea extract alone and in combination with sulfasalazine in experimentally induced inflammatory bowel disease in rats. Digestive diseases and sciences, 2011, Volume: 56, Issue:5 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Camellia sinensis; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Inflammatory Bowel Diseases; Lipid Peroxidation; Male; Malondialdehyde; Peroxidase; Plant Extracts; Rats; Rats, Wistar; Sulfasalazine; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha	2011
Dietary polydextrose prevents inflammatory bowel disease in trinitrobenzenesulfonic acid model of rat colitis. Journal of medicinal food, 2010, Volume: 13, Issue:6 Topics: Alkaline Phosphatase; Animals; Anti-Inflammatory Agents, Non-Steroidal; Colitis; Colon; Drug Interactions; Gastrointestinal Agents; Glucans; Glutathione; Inflammatory Bowel Diseases; Male; Organ Size; Oxidative Stress; Peroxidase; Prebiotics; Random Allocation; Rats; Rats, Wistar; Severity of Illness Index; Sulfasalazine; Trinitrobenzenesulfonic Acid	2010
Blockade of complement activation product C5a activity using specific antibody attenuates intestinal damage in trinitrobenzene sulfonic acid induced model of colitis. Laboratory investigation; a journal of technical methods and pathology, 2011, Volume: 91, Issue:3 Topics: Animals; Antibodies, Neutralizing; Colitis; Colon; Complement Activation; Complement C5a; Cytokines; Humans; Immunotherapy; Inflammatory Bowel Diseases; Intestinal Mucosa; Lymphocyte Count; Male; Mice; Mice, Inbred BALB C; Neutrophil Infiltration; Receptor, Anaphylatoxin C5a; RNA, Messenger; Severity of Illness Index; Th2 Cells; Time Factors; Trinitrobenzenesulfonic Acid	2011
Essential role for mast cell tryptase in acute experimental colitis. Proceedings of the National Academy of Sciences of the United States of America, 2011, Jan-04, Volume: 108, Issue:1 Topics: Animals; Chemokines; Colon; Cytokines; Dextran Sulfate; Enzyme-Linked Immunosorbent Assay; Immunohistochemistry; Inflammatory Bowel Diseases; Mast Cells; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; Microarray Analysis; Polymerase Chain Reaction; Trinitrobenzenesulfonic Acid; Tryptases	2011
The intestinal anti-inflammatory effect of minocycline in experimental colitis involves both its immunomodulatory and antimicrobial properties. Pharmacological research, 2011, Volume: 63, Issue:4 Topics: Animals; Anti-Inflammatory Agents; Caco-2 Cells; Cell Line; Colitis; Dextran Sulfate; Female; Humans; Immunologic Factors; Inflammatory Bowel Diseases; Macrophages; Mice; Mice, Inbred C57BL; Minocycline; Rats; Rats, Wistar; Trinitrobenzenesulfonic Acid	2011
Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease. Gut, 2011, Volume: 60, Issue:4 Topics: Animals; Caco-2 Cells; Chenodeoxycholic Acid; Colon; Cytokines; Dextran Sulfate; Disease Models, Animal; Drug Evaluation, Preclinical; Gene Expression Regulation; Humans; Ileum; Inflammation Mediators; Inflammatory Bowel Diseases; Intestinal Absorption; Mice; Mice, Inbred C57BL; Receptors, Cytoplasmic and Nuclear; Reverse Transcriptase Polymerase Chain Reaction; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha	2011
Treatment with Bifidobacterium bifidum 17 partially protects mice from Th1-driven inflammation in a chemically induced model of colitis. International journal of food microbiology, 2011, Sep-01, Volume: 149, Issue:1 Topics: Animals; Bifidobacterium; Colitis; Crohn Disease; Cytokines; Disease Models, Animal; Inflammation Mediators; Inflammatory Bowel Diseases; Interleukin-1beta; Intestinal Mucosa; Male; Mice; Mice, Inbred C57BL; Probiotics; T-Lymphocytes, Helper-Inducer; Trinitrobenzenesulfonic Acid	2011
Rectal gel application of Withania somnifera root extract expounds anti-inflammatory and muco-restorative activity in TNBS-induced inflammatory bowel disease. BMC complementary and alternative medicine, 2011, Apr-28, Volume: 11 Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Female; Gels; Hydrogen Peroxide; Inflammatory Bowel Diseases; Intestinal Mucosa; Lipid Peroxidation; Male; Nitrous Oxide; Phytotherapy; Plant Extracts; Plant Roots; Rats; Rats, Wistar; Reference Values; Trinitrobenzenesulfonic Acid; Withania	2011
Increasing endogenous 2-arachidonoylglycerol levels counteracts colitis and related systemic inflammation. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2011, Volume: 25, Issue:8 Topics: Animals; Arachidonic Acids; Benzodioxoles; Colitis; Disease Models, Animal; Endocannabinoids; Endotoxemia; Enzyme Inhibitors; Glycerides; Humans; Indoles; Inflammation; Inflammation Mediators; Inflammatory Bowel Diseases; Male; Mice; Mice, Inbred C57BL; Monoacylglycerol Lipases; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant; Trinitrobenzenesulfonic Acid	2011
Development of non-antibiotic macrolide that corrects inflammation-driven immune dysfunction in models of inflammatory bowel diseases and arthritis. European journal of pharmacology, 2011, Aug-31, Volume: 665, Issue:1-3 Topics: Animals; Anti-Inflammatory Agents; Arthritis; Azithromycin; CD11b Antigen; Colitis; Collagen; Dextran Sulfate; Disease Models, Animal; Drug Discovery; Female; Humans; Immunologic Factors; Inflammation; Inflammatory Bowel Diseases; Male; Mice; Mucous Membrane; NF-kappa B; Signal Transduction; Trinitrobenzenesulfonic Acid	2011
Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract. Gastroenterology, 2011, Volume: 141, Issue:1 Topics: Adult; Animals; Basic Helix-Loop-Helix Transcription Factors; Biopsy; Carbazoles; Case-Control Studies; Cells, Cultured; Dextran Sulfate; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Flow Cytometry; Humans; Inflammation Mediators; Inflammatory Bowel Diseases; Interleukin-22; Interleukins; Intestines; Mice; Mice, Inbred BALB C; Middle Aged; Polymerase Chain Reaction; Receptors, Aryl Hydrocarbon; Severity of Illness Index; Signal Transduction; T-Lymphocytes; Time Factors; Trinitrobenzenesulfonic Acid; Up-Regulation	2011
Impaired integrity of DNA after recovery from inflammation causes persistent dysfunction of colonic smooth muscle. Gastroenterology, 2011, Volume: 141, Issue:4 Topics: Acetylcholine; Animals; Calcium Channels, L-Type; Colitis; Colon; Disease Models, Animal; DNA Damage; Dose-Response Relationship, Drug; Gastrointestinal Motility; Hydrogen Peroxide; Inflammatory Bowel Diseases; Intestinal Mucosa; Isothiocyanates; Male; Muscle, Smooth; NF-E2-Related Factor 2; Oxidative Stress; Polymerase Chain Reaction; Promoter Regions, Genetic; Rats; Sulfoxides; Thiocyanates; Time Factors; Trinitrobenzenesulfonic Acid	2011
Ultrasound elasticity imaging for detecting intestinal fibrosis and inflammation in rats and humans with Crohn's disease. Gastroenterology, 2011, Volume: 141, Issue:3 Topics: Animals; Biomechanical Phenomena; Colitis; Colon; Crohn Disease; Diagnosis, Differential; Diagnostic Imaging; Disease Models, Animal; Disease Progression; Elasticity; Female; Fibrosis; Humans; Inflammation; Inflammatory Bowel Diseases; Intestine, Small; Pilot Projects; Rats; Rats, Inbred Lew; Trinitrobenzenesulfonic Acid; Ultrasonography	2011
The effect of phosphodiesterase-5 inhibition by sildenafil citrate on inflammation and apoptosis in rat experimental colitis. Life sciences, 2011, Sep-12, Volume: 89, Issue:11-12 Topics: Animals; Apoptosis; Colitis; Female; Glutathione; Inflammatory Bowel Diseases; Interleukin-10; Male; Malondialdehyde; NG-Nitroarginine Methyl Ester; Peroxidase; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Sildenafil Citrate; Sulfones; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha	2011
Effect of combination of thalidomide and sulfasalazine in experimentally induced inflammatory bowel disease in rats. Indian journal of experimental biology, 2011, Volume: 49, Issue:9 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Colon; Disease Models, Animal; Drug Therapy, Combination; Female; Immunosuppressive Agents; Inflammatory Bowel Diseases; Intestinal Mucosa; Male; Rats; Rats, Wistar; Sulfasalazine; Thalidomide; Treatment Outcome; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha	2011
Selective glucocorticoid receptor agonists for the treatment of inflammatory bowel disease: studies in mice with acute trinitrobenzene sulfonic acid colitis. The Journal of pharmacology and experimental therapeutics, 2012, Volume: 341, Issue:1 Topics: Acute Disease; Animals; Benzofurans; Benzoxazines; Caco-2 Cells; Cells, Cultured; Colitis; HEK293 Cells; Humans; Inflammatory Bowel Diseases; Male; Mice; Mice, Inbred BALB C; Receptors, Glucocorticoid; Treatment Outcome; Trinitrobenzenesulfonic Acid	2012
Effect of COX-2 inhibitor lumiracoxib and the TNF-α antagonist etanercept on TNBS-induced colitis in Wistar rats. Journal of molecular histology, 2012, Volume: 43, Issue:3 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Colitis; Colon; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Diclofenac; Disease Models, Animal; Down-Regulation; Drug Therapy, Combination; Etanercept; Humans; Immunoglobulin G; Inflammatory Bowel Diseases; Male; Random Allocation; Rats; Rats, Wistar; Receptors, Tumor Necrosis Factor; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha	2012
Spores from two distinct colony types of the strain Bacillus subtilis PB6 substantiate anti-inflammatory probiotic effects in mice. Clinical nutrition (Edinburgh, Scotland), 2012, Volume: 31, Issue:6 Topics: Animals; Anti-Inflammatory Agents; Bacillus subtilis; Body Weight; Cell Line; Colitis; Disease Models, Animal; Humans; Inflammatory Bowel Diseases; Interferon-gamma; Interleukin-10; Interleukin-12; Leukocytes, Mononuclear; Mice; Neutrophils; Probiotics; Serum Amyloid A Protein; Spores, Bacterial; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha	2012
Reappraisal of total body irradiation followed by bone marrow transplantation as a therapy for inflammatory bowel disease. Immunobiology, 2013, Volume: 218, Issue:3 Topics: Animals; Bone Marrow Transplantation; Colitis; Combined Modality Therapy; Cytokines; Disease Models, Animal; Female; Humans; Immunosuppression Therapy; Inflammation Mediators; Inflammatory Bowel Diseases; Male; Mice; Mice, Inbred BALB C; Trinitrobenzenesulfonic Acid; Weight Gain; Whole-Body Irradiation	2013
[Comparative study of novel therapeutic possibilities in animal experimental model of inflammatory bowel disease]. Magyar sebeszet, 2012, Volume: 65, Issue:4 Topics: Administration, Oral; Animals; Biomarkers; Colitis; Disease Models, Animal; Excitatory Amino Acid Antagonists; Inflammation; Inflammatory Bowel Diseases; Intestinal Mucosa; Kynurenic Acid; Microcirculation; Microscopy, Confocal; Peroxidase; Phosphatidylcholines; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha	2012
Protective and aggravating effects of Nlrp3 inflammasome activation in IBD models: influence of genetic and environmental factors. Digestive diseases (Basel, Switzerland), 2012, Volume: 30 Suppl 1 Topics: Animals; Anti-Bacterial Agents; Carrier Proteins; Colitis; Dendritic Cells; Disease Models, Animal; Environment; Epithelial Cells; Genetic Predisposition to Disease; Humans; Immune Tolerance; Inflammasomes; Inflammatory Bowel Diseases; Intestines; Metagenome; Mice; Mucous Membrane; NLR Family, Pyrin Domain-Containing 3 Protein; Phenotype; Protective Agents; Trinitrobenzenesulfonic Acid	2012
A low dose of fermented soy germ alleviates gut barrier injury, hyperalgesia and faecal protease activity in a rat model of inflammatory bowel disease. PloS one, 2012, Volume: 7, Issue:11 Topics: Animals; Cytokines; Disease Models, Animal; Enzyme Activation; Feces; Female; Glycine max; Humans; Hyperalgesia; Inflammatory Bowel Diseases; Intestinal Mucosa; Peptide Hydrolases; Permeability; Plant Extracts; Rats; Receptor, PAR-2; Trinitrobenzenesulfonic Acid; Weight Loss	2012
Glutamine treatment attenuates endoplasmic reticulum stress and apoptosis in TNBS-induced colitis. PloS one, 2012, Volume: 7, Issue:11 Topics: Animals; Apoptosis; Brefeldin A; Caco-2 Cells; Caspases; Cell Line, Tumor; Cell Survival; Colitis; Endoplasmic Reticulum; Glutamine; Humans; Immunohistochemistry; Inflammatory Bowel Diseases; Male; Oxidative Stress; Phosphorylation; Rats; Rats, Wistar; Thiobarbituric Acid Reactive Substances; Transcription Factor CHOP; Trinitrobenzenesulfonic Acid; Tunicamycin	2012
Relevance of TNBS-colitis in rats: a methodological study with endoscopic, histologic and Transcriptomic [corrected] characterization and correlation to IBD. PloS one, 2013, Volume: 8, Issue:1 Topics: Animals; Biopsy; Colonoscopy; Disease Models, Animal; Female; Gene Expression Profiling; Gene Expression Regulation; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Rats; Reproducibility of Results; Transcriptome; Trinitrobenzenesulfonic Acid	2013
Experimental murine colitis is regulated by two genetic loci, including one on chromosome 11 that regulates IL-12 responses. Gastroenterology, 2002, Volume: 123, Issue:2 Topics: Animals; Chromosome Mapping; Colitis; Female; Genetic Predisposition to Disease; Genotype; Inflammatory Bowel Diseases; Interleukin-12; Male; Mice; Mice, Inbred C57BL; Sex Factors; Trinitrobenzenesulfonic Acid	2002
Endothelin in human inflammatory bowel disease: comparison to rat trinitrobenzenesulphonic acid-induced colitis. Life sciences, 2002, Sep-06, Volume: 71, Issue:16 Topics: Animals; Colitis; Dinoprostone; Endothelin-1; Endothelin-2; Endothelins; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; L-Lactate Dehydrogenase; Male; Peroxidase; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha	2002
Use of mouse models to evaluate the persistence, safety, and immune modulation capacities of lactic acid bacteria. Clinical and diagnostic laboratory immunology, 2003, Volume: 10, Issue:4 Topics: Administration, Oral; Administration, Rectal; Animals; Bacterial Translocation; Colitis; Colon; Cytokines; Disease Models, Animal; Drug Evaluation, Preclinical; Ileum; Immune System; Inflammatory Bowel Diseases; Intestinal Mucosa; Lactobacillus; Lymph Nodes; Mice; Probiotics; RNA, Messenger; Safety; Species Specificity; Spleen; Stomach; Trinitrobenzenesulfonic Acid	2003
The suppressive effect of bifidobacteria on Bacteroides vulgatus, a putative pathogenic microbe in inflammatory bowel disease. Microbiology and immunology, 2003, Volume: 47, Issue:6 Topics: Administration, Rectal; Animals; Antibodies, Bacterial; Bacteroides; Bacteroides Infections; Bifidobacterium; Coculture Techniques; Colitis; Disease Models, Animal; Germ-Free Life; Haptens; Immunoglobulin G; Immunoglobulin kappa-Chains; Inflammatory Bowel Diseases; Mice; Mice, Inbred BALB C; Peanut Agglutinin; Peyer's Patches; Probiotics; Receptors, Mitogen; Species Specificity; Trinitrobenzenesulfonic Acid	2003
CCR6 has a non-redundant role in the development of inflammatory bowel disease. European journal of immunology, 2003, Volume: 33, Issue:10 Topics: Animals; Chemokine CCL20; Chemokines, CC; Colitis; Cytokines; Dextran Sulfate; Disease Susceptibility; Inflammatory Bowel Diseases; Macrophage Inflammatory Proteins; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Receptors, CCR6; Receptors, Chemokine; RNA, Messenger; Trinitrobenzenesulfonic Acid	2003
N-3 fatty acid-rich diet prevents early response of interleukin-6 elevation in trinitrobenzene sulfonic acid-induced enteritis. International journal of molecular medicine, 2003, Volume: 12, Issue:5 Topics: alpha-Linolenic Acid; Animal Feed; Animals; Diet; Disease Progression; Enteritis; Inflammatory Bowel Diseases; Interleukin-6; Male; Rats; Rats, Sprague-Dawley; Trinitrobenzenesulfonic Acid	2003
Imaging of intestinal lymphocyte homing by means of pinhole SPECT in a TNBS colitis mouse model. Nuclear medicine and biology, 2004, Volume: 31, Issue:1 Topics: Animals; Cell Movement; Colitis; Colon; Disease Models, Animal; Female; Inflammatory Bowel Diseases; Lymphocytes; Mice; Mice, Inbred BALB C; Organometallic Compounds; Oxyquinoline; Radiopharmaceuticals; Receptors, Lymphocyte Homing; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Trinitrobenzenesulfonic Acid	2004
Yersinia pseudotuberculosis anti-inflammatory components reduce trinitrobenzene sulfonic acid-induced colitis in the mouse. Infection and immunity, 2004, Volume: 72, Issue:4 Topics: Animals; Colitis; Disease Models, Animal; Female; Humans; Inflammation; Inflammatory Bowel Diseases; Mice; Mice, Inbred C57BL; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha; Yersinia pseudotuberculosis; Yersinia pseudotuberculosis Infections	2004
Reduction of Smad3 accelerates re-epithelialization in a murine model of colitis. Biochemical and biophysical research communications, 2004, Apr-30, Volume: 317, Issue:2 Topics: Animals; Cell Division; Colitis; Disease Models, Animal; DNA-Binding Proteins; Inflammatory Bowel Diseases; Intestinal Mucosa; Male; Mice; Mice, Inbred C57BL; Regeneration; Severity of Illness Index; Smad3 Protein; Trans-Activators; Transforming Growth Factor beta; Trinitrobenzenesulfonic Acid; Wound Healing	2004
A role for proteinase-activated receptor-1 in inflammatory bowel diseases. The Journal of clinical investigation, 2004, Volume: 114, Issue:10 Topics: Adult; Animals; B-Lymphocytes; Colitis; Colon; Dextran Sulfate; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Humans; Immunohistochemistry; Inflammatory Bowel Diseases; Intestinal Mucosa; Kinetics; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Peptide Fragments; Permeability; Peroxidase; Receptor, PAR-1; RNA, Messenger; Survival Rate; T-Lymphocytes; Thrombin; Trinitrobenzenesulfonic Acid	2004
[Modulation of intestinal mucosal inflammatory factors by curcumin in rats with colitis]. Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA, 2004, Volume: 24, Issue:12 Topics: Animals; Curcumin; Inflammatory Bowel Diseases; Interleukin-1; Interleukin-10; Interleukin-4; Intestinal Mucosa; Male; NF-kappa B; Random Allocation; Rats; Rats, Wistar; RNA, Messenger; Trinitrobenzenesulfonic Acid	2004
The presentation of haptenated proteins and activation of T cells in the mesenteric lymph nodes by dendritic cells in the TNBS colitis rat. Annals of the New York Academy of Sciences, 2004, Volume: 1029 Topics: Animals; Colitis; Dendritic Cells; Disease Models, Animal; Haptens; Inflammatory Bowel Diseases; Lymph Nodes; Rats; T-Lymphocytes; Trinitrobenzenesulfonic Acid	2004
Therapeutic efficacy of pycnogenol in experimental inflammatory bowel diseases. Phytotherapy research : PTR, 2004, Volume: 18, Issue:12 Topics: Adjuvants, Immunologic; Animals; Dose-Response Relationship, Drug; Flavonoids; Inflammatory Bowel Diseases; Male; Pinus; Plant Extracts; Rats; Rats, Sprague-Dawley; Trinitrobenzenesulfonic Acid	2004
A potent and selective inhibitor of group IIa secretory phospholipase A2 protects rats from TNBS-induced colitis. International immunopharmacology, 2005, Volume: 5, Issue:5 Topics: Animals; Body Weight; Colitis; Disease Models, Animal; Eating; Edema; Enzyme Inhibitors; Female; Group II Phospholipases A2; Humans; Hypertension; Inflammatory Bowel Diseases; Lipopolysaccharides; Neutropenia; Pentanoic Acids; Peroxidase; Phospholipases A; Phospholipases A2; Rats; Rats, Wistar; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha	2005
Protection against 2,4,6-trinitrobenzenesulphonic acid-induced colonic inflammation in mice by the marine products bolinaquinone and petrosaspongiolide M. Biochemical pharmacology, 2005, May-15, Volume: 69, Issue:10 Topics: Animals; Anti-Inflammatory Agents; Calcium-Binding Proteins; Colitis; Cyclooxygenase 2; Dysidea; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Immunohistochemistry; Inflammatory Bowel Diseases; Interleukin-1; Male; Membrane Glycoproteins; Membrane Proteins; Mice; Mice, Inbred BALB C; Nerve Tissue Proteins; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Oleanolic Acid; Prostaglandin-Endoperoxide Synthases; Sesquiterpenes; Synaptotagmin I; Synaptotagmins; Trinitrobenzenesulfonic Acid	2005
Time-course expression of Toll-like receptors 2 and 4 in inflammatory bowel disease and homeostatic effect of VIP. Journal of leukocyte biology, 2005, Volume: 78, Issue:2 Topics: Animals; Autoimmune Diseases; Gene Expression Regulation; Homeostasis; Inflammation; Inflammatory Bowel Diseases; Injections, Intraperitoneal; Interferon-gamma; Interleukin-1; Intestinal Mucosa; Intestines; Male; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Neuroprotective Agents; Receptors, Cell Surface; Recovery of Function; Toll-Like Receptor 2; Toll-Like Receptors; Trinitrobenzenesulfonic Acid; Vasoactive Intestinal Peptide	2005
Increased potency of a novel complement factor 5a receptor antagonist in a rat model of inflammatory bowel disease. The Journal of pharmacology and experimental therapeutics, 2005, Volume: 314, Issue:2 Topics: Animals; Biological Availability; Biotransformation; Complement C5a; Digestive System; Eating; Edema; Female; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Peptides, Cyclic; Rats; Rats, Wistar; Receptors, Complement; Trinitrobenzenesulfonic Acid; Ulcer; Weight Loss	2005
Effects of hepatocyte growth factor on rat inflammatory bowel disease models. Digestive diseases and sciences, 2005, Volume: 50, Issue:5 Topics: Animals; Apoptosis; Cell Proliferation; Colon; Dextran Sulfate; Disease Models, Animal; Epithelial Cells; Hepatocyte Growth Factor; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Male; Mitogens; Rats; Rats, Wistar; Recombinant Proteins; Regeneration; Treatment Outcome; Trinitrobenzenesulfonic Acid	2005
Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of inflammatory bowel disease. Immunology letters, 2005, Nov-15, Volume: 101, Issue:2 Topics: 4-1BB Ligand; Animals; Antibodies, Monoclonal; Apoptosis; Body Weight; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Female; Immunotherapy; Inflammatory Bowel Diseases; Interleukin-2; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Survival Rate; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factors	2005
[Study the effect and mechanism of thalidomide in model of inflammatory bowed disease]. Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition, 2005, Volume: 36, Issue:4 Topics: Animals; Colitis, Ulcerative; Crohn Disease; Female; Inflammatory Bowel Diseases; NF-kappa B; Oxazolone; Rats; Rats, Sprague-Dawley; Thalidomide; Trinitrobenzenesulfonic Acid	2005
Pharmacokinetics of 7-carboxymethyloxy-3',4',5-trimethoxy flavone (DA-6034), a derivative of flavonoid, in mouse and rat models of chemically-induced inflammatory bowel disease. The Journal of pharmacy and pharmacology, 2006, Volume: 58, Issue:1 Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Dextran Sulfate; Female; Flavonoids; Inflammatory Bowel Diseases; Injections, Intravenous; Intestine, Small; Male; Mice; Mice, Inbred ICR; Oxazolone; Rats; Rats, Sprague-Dawley; Trinitrobenzenesulfonic Acid	2006
Up-regulation of anandamide levels as an endogenous mechanism and a pharmacological strategy to limit colon inflammation. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2006, Volume: 20, Issue:3 Topics: Adult; Aged; Amidohydrolases; Animals; Arachidonic Acids; Benzenesulfonates; Colitis; Colitis, Ulcerative; Colon; Disease Models, Animal; Drug Evaluation, Preclinical; Endocannabinoids; Female; Glycerides; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Male; Mesalamine; Mice; Mice, Inbred C57BL; Middle Aged; Peroxidase; Polyunsaturated Alkamides; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Serotonin; Specific Pathogen-Free Organisms; Trinitrobenzenesulfonic Acid	2006
Inflammatory bowel disease requires the interplay between innate and adaptive immune signals. Cell research, 2006, Volume: 16, Issue:1 Topics: Animals; Cells, Cultured; Colitis; Dose-Response Relationship, Drug; Homeodomain Proteins; Immunity, Innate; Inflammatory Bowel Diseases; Interferon-gamma; Lipopolysaccharides; Macrophages; Mice; Mice, Inbred C57BL; Nitric Oxide; omega-N-Methylarginine; Th1 Cells; Toll-Like Receptor 4; Trinitrobenzenesulfonic Acid	2006
Cortistatin, an antiinflammatory peptide with therapeutic action in inflammatory bowel disease. Proceedings of the National Academy of Sciences of the United States of America, 2006, Mar-14, Volume: 103, Issue:11 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cytokines; Disease Models, Animal; Humans; Immunity, Mucosal; In Vitro Techniques; Inflammation Mediators; Inflammatory Bowel Diseases; Macrophages; Mice; Mice, Inbred BALB C; Neuropeptides; Th1 Cells; Trinitrobenzenesulfonic Acid	2006
Anti-inflammatory potential of the probiotic dietary supplement Lactibiane Tolérance: in vitro and in vivo considerations. Clinical nutrition (Edinburgh, Scotland), 2006, Volume: 25, Issue:6 Topics: Animals; Anti-Inflammatory Agents; Bifidobacterium; Cells, Cultured; Colitis; Cytokines; Dietary Supplements; Disease Models, Animal; Female; Humans; Inflammatory Bowel Diseases; Lactobacillus; Leukocytes, Mononuclear; Mice; Mice, Inbred BALB C; Probiotics; Random Allocation; Severity of Illness Index; Treatment Outcome; Trinitrobenzenesulfonic Acid	2006
No evidence for an involvement of the p38 and JNK mitogen-activated protein in inflammatory bowel diseases. Digestive diseases and sciences, 2006, Volume: 51, Issue:8 Topics: Adult; Animals; Blotting, Western; Colitis, Ulcerative; Disease Models, Animal; Enzyme Inhibitors; Female; Gene Expression; Humans; Imidazoles; Inflammatory Bowel Diseases; Interleukin-1; Intestinal Mucosa; JNK Mitogen-Activated Protein Kinases; Male; Mice; Mice, Inbred BALB C; Middle Aged; p38 Mitogen-Activated Protein Kinases; Polymerase Chain Reaction; Prognosis; Pyridines; RNA, Messenger; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha	2006
Non-viral delivery of nuclear factor-kappaB decoy ameliorates murine inflammatory bowel disease and restores tissue homeostasis. Gut, 2007, Volume: 56, Issue:4 Topics: Animals; Colon; Dextran Sulfate; Disease Models, Animal; Female; Gene Transfer Techniques; Genetic Therapy; Homeostasis; Inflammation Mediators; Inflammatory Bowel Diseases; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Microscopy, Confocal; NF-kappa B; Oligodeoxyribonucleotides; Oxazolone; Trinitrobenzenesulfonic Acid	2007
Glucocorticoid-induced tumour necrosis factor receptor family-related receptor signalling exacerbates hapten-induced colitis by CD4+ T cells. Immunology, 2006, Volume: 119, Issue:4 Topics: Animals; CD4-Positive T-Lymphocytes; Cytokines; Disease Models, Animal; Female; Glucocorticoid-Induced TNFR-Related Protein; Haptens; Immunity, Mucosal; Immunoglobulin A; Immunoglobulin G; Inflammatory Bowel Diseases; Intestinal Mucosa; Lymph Nodes; Mice; Mice, Inbred BALB C; Receptors, Nerve Growth Factor; Receptors, Tumor Necrosis Factor; Signal Transduction; Trinitrobenzenesulfonic Acid	2006
Comparative analysis of colonic gene expression of three experimental colitis models mimicking inflammatory bowel disease. Inflammatory bowel diseases, 2007, Volume: 13, Issue:3 Topics: Animals; Colitis; Dextran Sulfate; Disease Models, Animal; Female; Gene Expression; Inflammatory Bowel Diseases; Leukocyte Common Antigens; Mice; Mice, Inbred BALB C; Mice, SCID; Oligonucleotide Array Sequence Analysis; T-Lymphocytes; Trinitrobenzenesulfonic Acid	2007
Remission-inducing effect of anti-TNF monoclonal antibody in TNBS colitis: mechanisms beyond neutralization? Inflammatory bowel diseases, 2007, Volume: 13, Issue:3 Topics: Amino Acid Chloromethyl Ketones; Animals; Antibodies, Monoclonal; Apoptosis; Caspase Inhibitors; Colitis; Down-Regulation; Inflammatory Bowel Diseases; Infliximab; Interferon-gamma; Interleukin-18; Male; Mice; Mice, Inbred C57BL; Oxazolone; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha	2007
A comparative study of the preventative effects exerted by two probiotics, Lactobacillus reuteri and Lactobacillus fermentum, in the trinitrobenzenesulfonic acid model of rat colitis. The British journal of nutrition, 2007, Volume: 97, Issue:1 Topics: Animals; Colitis; Colon; Diarrhea; Fatty Acids, Volatile; Feces; Female; Gastrointestinal Contents; Glutathione; Hydrogen-Ion Concentration; Inflammatory Bowel Diseases; Intestinal Mucosa; Limosilactobacillus fermentum; Limosilactobacillus reuteri; Models, Animal; Muscle, Skeletal; Organ Size; Peroxidase; Probiotics; Rats; Rats, Wistar; Spleen; Thymus Gland; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha	2007
Bile synthesis in rat models of inflammatory bowel diseases. European journal of clinical investigation, 2007, Volume: 37, Issue:3 Topics: Animals; Bile Acids and Salts; Colitis; Dextran Sulfate; Indomethacin; Inflammatory Bowel Diseases; Male; Models, Biological; NF-kappa B; Rats; Rats, Wistar; Transcription Factor AP-1; Trinitrobenzenesulfonic Acid	2007
The proinflammatory effect of prostaglandin E2 in experimental inflammatory bowel disease is mediated through the IL-23-->IL-17 axis. Journal of immunology (Baltimore, Md. : 1950), 2007, Jun-15, Volume: 178, Issue:12 Topics: Animals; Anti-Ulcer Agents; Colitis; Colon; Cytokines; Dendritic Cells; Dinoprostone; Disease Models, Animal; Inflammatory Bowel Diseases; Interleukin-12; Interleukin-17; Interleukin-23; Interleukins; Intestinal Mucosa; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; Misoprostol; Neutrophils; T-Lymphocytes, Helper-Inducer; Trinitrobenzenesulfonic Acid	2007
The therapeutic effect of glatiramer acetate in a murine model of inflammatory bowel disease is mediated by anti-inflammatory T-cells. Immunology letters, 2007, Oct-15, Volume: 112, Issue:2 Topics: Adoptive Transfer; Animals; Dextran Sulfate; Disease Models, Animal; Glatiramer Acetate; Humans; Immunohistochemistry; Immunologic Factors; Inflammatory Bowel Diseases; Interleukin-10; Mice; Mice, Inbred C57BL; Peptides; Spleen; T-Lymphocytes, Regulatory; Th2 Cells; Transforming Growth Factor beta; Trinitrobenzenesulfonic Acid	2007
[Studies on the influence of Candida fungal colonization on the healing process of inflammatory lesions in the colon in rat animal model]. Przeglad lekarski, 2007, Volume: 64, Issue:3 Topics: Administration, Rectal; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Candidiasis; Disease Models, Animal; Fluconazole; Inflammatory Bowel Diseases; Interleukin-1beta; Male; Probiotics; Rats; Rats, Wistar; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha; Wound Healing	2007
[Effect of schistosome ova on Trinitrobenzenesulfonic acid induced colitis in mice]. Zhonghua yi xue za zhi, 2007, Aug-14, Volume: 87, Issue:30 Topics: Animals; Colon; Immunohistochemistry; Inflammatory Bowel Diseases; Injections, Intraperitoneal; Intestinal Mucosa; Male; Mice; Mice, Inbred BALB C; Ovum; Random Allocation; Reverse Transcriptase Polymerase Chain Reaction; Schistosoma japonicum; Toll-Like Receptor 4; Trinitrobenzenesulfonic Acid	2007
Prolonged chronic inflammation progresses to dysplasia in a novel rat model of colitis-associated colon cancer. Cancer research, 2007, Nov-15, Volume: 67, Issue:22 Topics: 1,2-Dimethylhydrazine; Adenomatous Polyposis Coli Protein; Animals; Carcinoma; Chronic Disease; Colitis; Colonic Neoplasms; Exons; Inflammation; Inflammatory Bowel Diseases; Mutation; Rats; Time Factors; Trinitrobenzenesulfonic Acid; Tumor Suppressor Protein p53	2007
Effects of Lactobacillus salivarius 433118 on intestinal inflammation, immunity status and in vitro colon function in two mouse models of inflammatory bowel disease. Digestive diseases and sciences, 2008, Volume: 53, Issue:9 Topics: Animals; Cell Membrane Permeability; Colitis; Colon; Cytokines; Disease Models, Animal; Feces; Immunity; Inflammatory Bowel Diseases; Interleukin-10; Lactobacillus; Mannitol; Mice; Mice, Inbred C57BL; Mice, Knockout; Probiotics; Trinitrobenzenesulfonic Acid	2008
Suppression of colon inflammation by CD80 blockade: evaluation in two murine models of inflammatory bowel disease. Inflammatory bowel diseases, 2008, Volume: 14, Issue:4 Topics: Adoptive Transfer; Animals; B7-1 Antigen; Binding, Competitive; Colitis; Colon; Cytokines; Female; Inflammation; Inflammatory Bowel Diseases; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Mice, SCID; Oligopeptides; T-Lymphocytes; Trinitrobenzenesulfonic Acid	2008
Protective effects of dietary curcumin in mouse model of chemically induced colitis are strain dependent. Inflammatory bowel diseases, 2008, Volume: 14, Issue:6 Topics: Animals; Colitis; Concanavalin A; Curcumin; Diet; Disease Models, Animal; Inflammatory Bowel Diseases; Lymphocytes; Male; Mice; Mice, Inbred BALB C; Mice, Inbred Strains; Microarray Analysis; Reverse Transcriptase Polymerase Chain Reaction; Species Specificity; Trinitrobenzenesulfonic Acid	2008
Abolishment of TNBS-induced visceral hypersensitivity in mast cell deficient rats. Life sciences, 2008, Feb-13, Volume: 82, Issue:7-8 Topics: Animals; Colon; Disease Models, Animal; Hyperalgesia; Inflammatory Bowel Diseases; Intestinal Mucosa; Male; Mast Cells; Necrosis; Pain Threshold; Peroxidase; Rats; Trinitrobenzenesulfonic Acid	2008
A critical role of CD30 ligand/CD30 in controlling inflammatory bowel diseases in mice. Gastroenterology, 2008, Volume: 134, Issue:2 Topics: Adjuvants, Immunologic; Animals; Antibodies, Monoclonal; CD30 Ligand; Colitis; Cytokines; Disease Models, Animal; Genetic Predisposition to Disease; Inflammatory Bowel Diseases; Interleukin-4; Intestinal Mucosa; Ki-1 Antigen; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Oxazolone; Signal Transduction; Trinitrobenzenesulfonic Acid	2008
[Therapeutic effects of mucosal tolerance on inflammatory bowel disease: experiment with rats]. Zhonghua yi xue za zhi, 2007, Nov-13, Volume: 87, Issue:42 Topics: Adjuvants, Immunologic; Animals; Immune Tolerance; Inflammatory Bowel Diseases; Intestinal Mucosa; Lipopolysaccharides; Male; Ovalbumin; Rats; Rats, Sprague-Dawley; Trinitrobenzenesulfonic Acid	2007
[Protective effect of epigallocatechin-3-gallate on inflammatory bowel disease: experiment with rat models of induced colitis]. Zhonghua yi xue za zhi, 2007, Nov-13, Volume: 87, Issue:42 Topics: Animals; Blotting, Western; Catechin; Cyclooxygenase 2; Disease Models, Animal; Gene Expression; Inflammatory Bowel Diseases; Intestinal Mucosa; Random Allocation; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Trinitrobenzenesulfonic Acid	2007
Oral IL-10 gene delivery in a microsphere-based formulation for local transfection and therapeutic efficacy in inflammatory bowel disease. Gene therapy, 2008, Volume: 15, Issue:17 Topics: Administration, Oral; Animals; Biomarkers; Chemistry, Pharmaceutical; Colon; Enzyme-Linked Immunosorbent Assay; Female; Gelatin; Gene Expression; Genetic Therapy; Inflammatory Bowel Diseases; Interleukin-10; Intestinal Mucosa; Mice; Mice, Inbred BALB C; Microscopy, Electron, Scanning; Microspheres; Models, Animal; Nanoparticles; Peroxidase; Reverse Transcriptase Polymerase Chain Reaction; Transfection; Transgenes; Trinitrobenzenesulfonic Acid	2008
Non-lymphoid cells in experimental inflammatory bowel disease. Advances in experimental medicine and biology, 1995, Volume: 371B Topics: Animals; Antibodies, Monoclonal; Colitis; Colon; Dendritic Cells; Disease Models, Animal; Ethanol; Histocompatibility Antigens Class II; Inflammatory Bowel Diseases; Intestinal Mucosa; Macrophages; Rats; Rats, Wistar; Trinitrobenzenesulfonic Acid	1995
Boosted systemic immune and local responsiveness after intestinal inflammation in orally sensitized guinea pigs. Gastroenterology, 1995, Volume: 109, Issue:1 Topics: Analysis of Variance; Animals; Cell Membrane Permeability; Colon; Edetic Acid; Guinea Pigs; Histamine Release; Immunization; Immunoglobulin E; Immunoglobulin G; Inflammatory Bowel Diseases; Intestinal Mucosa; Lactoglobulins; Male; Milk Hypersensitivity; Milk Proteins; Mucus; Trinitrobenzenesulfonic Acid	1995
The characterization of a rabbit model of inflammatory bowel disease. International journal of experimental pathology, 1995, Volume: 76, Issue:3 Topics: Animals; Colitis, Ulcerative; Crohn Disease; Disease Models, Animal; Dose-Response Relationship, Drug; Ethanol; Female; Inflammatory Bowel Diseases; Rabbits; Sodium Chloride; Time Factors; Trinitrobenzenesulfonic Acid	1995
Induction of nitric oxide synthase in rat intestine and its association with tissue injury. Agents and actions, 1993, Volume: 38 Spec No Topics: Amino Acid Oxidoreductases; Animals; Colon; Endotoxins; Enzyme Induction; Humans; Inflammatory Bowel Diseases; Jejunum; Nitric Oxide Synthase; Rats; Trinitrobenzenesulfonic Acid	1993
Non-lymphoid cells in acute and chronic experimental inflammatory bowel disease. Advances in experimental medicine and biology, 1994, Volume: 355 Topics: Acute Disease; Administration, Rectal; Animals; Antibodies, Monoclonal; Chronic Disease; Colitis; Dendritic Cells; Disease Models, Animal; Histocompatibility Antigens Class II; Inflammatory Bowel Diseases; Lymphocyte Subsets; Lymphoid Tissue; Macrophage-1 Antigen; Macrophages; Neutrophils; Peyer's Patches; Rats; Rats, Wistar; Severity of Illness Index; Trinitrobenzenesulfonic Acid	1994
Effect of leukotriene C4D4 antagonist on colonic damage induced by intracolonic administration of trinitrobenzene sulfonic acid in rats. Journal of gastroenterology, 1995, Volume: 30, Issue:1 Topics: Animals; Chromones; Colon; Disease Models, Animal; Eicosanoids; Female; Inflammatory Bowel Diseases; Leukotriene C4; Leukotriene D4; Methacrylates; Peroxidase; Phenylpropionates; Rats; Rats, Sprague-Dawley; SRS-A; Thromboxane-A Synthase; Trinitrobenzenesulfonic Acid	1995
Alterations in rat peripheral blood neutrophil function as a consequence of colitis. Digestive diseases and sciences, 1995, Volume: 40, Issue:1 Topics: Animals; Chemotaxis, Leukocyte; Colitis; Inflammatory Bowel Diseases; Leukocyte Count; Leukotriene B4; Male; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Phagocytosis; Rats; Rats, Wistar; Superoxides; Trinitrobenzenesulfonic Acid	1995
Effects of zileuton, a new 5-lipoxygenase inhibitor, in experimentally induced colitis in rats. Agents and actions, 1993, Volume: 39, Issue:3-4 Topics: Animals; Colitis; Colon; Eicosanoids; Hydroxyurea; Inflammatory Bowel Diseases; Leukocytes; Lipoxygenase Inhibitors; Male; Peroxidase; Rats; Rats, Wistar; Sulfasalazine; Trinitrobenzenesulfonic Acid	1993
Effect of a new de-N-acetyl-lysoglycosphingolipid on chemically-induced inflammatory bowel disease: possible mechanism of action. Naunyn-Schmiedeberg's archives of pharmacology, 1993, Volume: 348, Issue:6 Topics: Animals; Arachidonic Acid; Carbohydrate Sequence; Colitis; Colon; Gangliosides; Humans; Inflammatory Bowel Diseases; Leukotriene B4; Male; Malondialdehyde; Molecular Sequence Data; Organ Size; Pancreas; Peroxidase; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Platelet Aggregation Inhibitors; Rats; Rats, Wistar; Spleen; Synovial Fluid; Trinitrobenzenesulfonic Acid	1993
Macrophages and dendritic cells in rat colon in experimental inflammatory bowel disease. Advances in experimental medicine and biology, 1993, Volume: 329 Topics: Acute Disease; Animals; Antibodies, Monoclonal; Biomarkers; Chronic Disease; Colon; Dendritic Cells; Ethanol; Histocompatibility Antigens; Histocompatibility Antigens Class II; Inflammatory Bowel Diseases; Macrophages; Rats; Rats, Wistar; Trinitrobenzenesulfonic Acid	1993
The 21-aminosteroid tirilazad mesylate can ameliorate inflammatory bowel disease in rats. The Journal of pharmacology and experimental therapeutics, 1996, Volume: 276, Issue:1 Topics: Animals; Antioxidants; Body Weight; Colitis; Colon; Free Radical Scavengers; Inflammatory Bowel Diseases; Lipid Peroxides; Luminescent Measurements; Male; Organ Size; Peroxidase; Pregnatrienes; Rats; Rats, Sprague-Dawley; Superoxides; Trinitrobenzenesulfonic Acid	1996
Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protection by tolerance. Journal of immunology (Baltimore, Md. : 1950), 1996, Sep-01, Volume: 157, Issue:5 Topics: Administration, Oral; Administration, Rectal; Animals; Antibody Formation; CD4-Positive T-Lymphocytes; Cytokines; Disease Models, Animal; Epitopes; Female; Haptens; Immune Tolerance; Immunosuppressive Agents; Inflammatory Bowel Diseases; Intestinal Mucosa; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred DBA; Trinitrobenzenes; Trinitrobenzenesulfonic Acid	1996
The effect of alpha-linolenic acid-rich emulsion on fatty acid metabolism and leukotriene generation of the colon in a rat model with inflammatory bowel disease. Annals of nutrition & metabolism, 1996, Volume: 40, Issue:3 Topics: alpha-Linolenic Acid; Animals; Body Weight; Cholesterol; Colon; Disease Models, Animal; Fatty Acids; Glucose; Inflammatory Bowel Diseases; Leukotriene B4; Male; Phospholipids; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Soybean Proteins; Trinitrobenzenesulfonic Acid	1996
Colitis causes bone loss in rats through suppression of bone formation. Gastroenterology, 1996, Volume: 111, Issue:5 Topics: Animals; Bone Development; Bone Resorption; Colitis; Female; Inflammatory Bowel Diseases; Male; Osteoporosis; Rats; Rats, Wistar; Trinitrobenzenesulfonic Acid	1996
Application of natural products in experimental models of intestinal inflammation in rats. Methods and findings in experimental and clinical pharmacology, 1996, Volume: 18 Suppl B Topics: Acetic Acid; Alkaline Phosphatase; Animals; Biomarkers; Colitis; Disease Models, Animal; Humans; Inflammatory Bowel Diseases; Leukotriene B4; Peroxidase; Quercetin; Rats; Rutin; Trinitrobenzenesulfonic Acid	1996
Down-regulation of substance P receptors during colitis induced by trinitrobenzene sulfonic acid in rats. Neuropeptides, 1996, Volume: 30, Issue:5 Topics: Animals; Colitis; Disease Models, Animal; Down-Regulation; Haptens; Humans; Indoles; Inflammatory Bowel Diseases; Isoindoles; Male; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; Trinitrobenzenesulfonic Acid	1996
Histomorphometric evaluation of experimentally induced colitis with trinitrobenzene-sulphonic acid in rats. International journal of experimental pathology, 1996, Volume: 77, Issue:4 Topics: Acute Disease; Animals; Colitis; Colon; Disease Progression; Fibrosis; Inflammatory Bowel Diseases; Intestinal Mucosa; Male; Necrosis; Rats; Rats, Wistar; Time Factors; Trinitrobenzenesulfonic Acid	1996
Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice. European journal of immunology, 1997, Volume: 27, Issue:7 Topics: Animals; Antibodies; Chronic Disease; Colitis; Disease Models, Animal; Female; Inflammatory Bowel Diseases; Mice; Mice, Inbred Strains; Mice, Knockout; Mice, Transgenic; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha	1997
[Therapeutic effects of beclomethasone dipropionate enemas on colon damage of inflammatory bowel disease model rats]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 1998, Volume: 118, Issue:6 Topics: Animals; Anti-Inflammatory Agents; Beclomethasone; Colon; Disease Models, Animal; Dose-Response Relationship, Drug; Enema; Inflammatory Bowel Diseases; Male; Organ Size; Rats; Rats, Inbred F344; Trinitrobenzenesulfonic Acid	1998
Taurine can ameliorate inflammatory bowel disease in rats. Advances in experimental medicine and biology, 1998, Volume: 442 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Colon; Disease Models, Animal; Eicosanoids; Inflammatory Bowel Diseases; Luminescent Measurements; Luminol; Male; Peroxidase; Rats; Rats, Sprague-Dawley; Taurine; Trinitrobenzenesulfonic Acid	1998
Urinary 8-hydroxydeoxyguanosine excretion as a non-invasive marker of neutrophil activation in animal models of inflammatory bowel disease. Scandinavian journal of gastroenterology, 1998, Volume: 33, Issue:6 Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Chromatography, High Pressure Liquid; Deoxyguanosine; Dextran Sulfate; Enema; Hydroxyl Radical; Inflammatory Bowel Diseases; Intestines; Male; Neutrophil Activation; Peroxidase; Rats; Rats, Wistar; Trinitrobenzenesulfonic Acid	1998
Curative treatment of an experimentally induced colitis by a CD44 variant V7-specific antibody. Journal of immunology (Baltimore, Md. : 1950), 1998, Aug-01, Volume: 161, Issue:3 Topics: Animals; Antibodies, Monoclonal; Antibody Specificity; Colitis; Cytokines; Hyaluronan Receptors; Inflammatory Bowel Diseases; Intestinal Mucosa; Mice; Mice, Inbred BALB C; Th1 Cells; Trinitrobenzenesulfonic Acid	1998
[Effect of plaunotol on trinitrobenzene sulfonic acid and acetic acid induced colonic lesions in rats]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1998, Volume: 112, Issue:2 Topics: Acetic Acid; Animals; Anti-Ulcer Agents; Colon; Disease Models, Animal; Diterpenes; Dose-Response Relationship, Drug; Fatty Alcohols; Humans; Inflammatory Bowel Diseases; Male; Rats; Rats, Sprague-Dawley; Trinitrobenzenesulfonic Acid	1998
Protective effect of taurine on TNBS-induced inflammatory bowel disease in rats. Archives of pharmacal research, 1998, Volume: 21, Issue:5 Topics: Animals; Colitis; Colon; Dinoprostone; Eicosanoids; Inflammatory Bowel Diseases; Luminescent Measurements; Male; Peroxidase; Rats; Rats, Sprague-Dawley; Taurine; Trinitrobenzenesulfonic Acid	1998
Hapten-induced colitis is associated with colonic patch hypertrophy and T helper cell 2-type responses. The Journal of experimental medicine, 1999, Apr-19, Volume: 189, Issue:8 Topics: Animals; Antibodies; Colitis, Ulcerative; Colon; Disease Models, Animal; Haptens; Hypertrophy; Inflammatory Bowel Diseases; Interferon-gamma; Interleukin-4; Interleukin-5; Mice; Mice, Inbred BALB C; Mice, Knockout; Peyer's Patches; T-Lymphocytes, Helper-Inducer; Th1 Cells; Th2 Cells; Trinitrobenzenesulfonic Acid	1999
Effect of DA-6034, a derivative of flavonoid, on experimental animal models of inflammatory bowel disease. Archives of pharmacal research, 1999, Volume: 22, Issue:4 Topics: Acetic Acid; Animals; Animals, Genetically Modified; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; beta 2-Microglobulin; Colitis; Flavonoids; Gastrointestinal Agents; HLA-B27 Antigen; Humans; Inflammatory Bowel Diseases; Organ Size; Prednisolone; Rats; Sulfasalazine; Trinitrobenzenesulfonic Acid; Weight Loss	1999
Involvement of neutrophils and free radicals in the potentiating effects of passive cigarette smoking on inflammatory bowel disease in rats. Gastroenterology, 1999, Volume: 117, Issue:4 Topics: Animals; Colon; Enema; Ethanol; Free Radicals; Inflammatory Bowel Diseases; Leukotriene B4; Male; Neutrophils; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Peroxidase; Rats; Rats, Sprague-Dawley; Reference Values; RNA, Messenger; Superoxide Dismutase; Tobacco Smoke Pollution; Trinitrobenzenesulfonic Acid	1999
The effect of an inhibitor of matrix metalloproteinases on colonic inflammation in a trinitrobenzenesulphonic acid rat model of inflammatory bowel disease. Alimentary pharmacology & therapeutics, 1999, Volume: 13, Issue:11 Topics: Animals; Biological Availability; Colitis; Hydroxamic Acids; Inflammatory Bowel Diseases; Male; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Peroxidase; Protease Inhibitors; Rats; Rats, Wistar; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha	1999
Therapeutic effects of the endothelin receptor antagonist Ro 48-5695 in the TNBS/DNBS rat model of colitis. European journal of gastroenterology & hepatology, 2000, Volume: 12, Issue:3 Topics: Animals; Benzenesulfonates; Colitis, Ulcerative; Disease Models, Animal; Endothelin Receptor Antagonists; Endothelin-1; Inflammatory Bowel Diseases; Male; Peroxidase; Rats; Rats, Sprague-Dawley; Sulfonamides; Trinitrobenzenesulfonic Acid	2000
Replenishment of glutathione levels improves mucosal function in experimental acute colitis. Laboratory investigation; a journal of technical methods and pathology, 2000, Volume: 80, Issue:5 Topics: Acetylcysteine; Acute Disease; Animals; Colitis; Ethanol; Glutathione; Inflammatory Bowel Diseases; Intestinal Mucosa; Male; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Time Factors; Trinitrobenzenesulfonic Acid	2000
Abrogation of experimental colitis correlates with increased apoptosis in mice deficient for CD44 variant exon 7 (CD44v7). The Journal of experimental medicine, 2000, Jun-19, Volume: 191, Issue:12 Topics: Adoptive Transfer; Animals; Apoptosis; Bone Marrow Transplantation; CD40 Antigens; Colitis; Colon; Exons; Hyaluronan Receptors; Inflammatory Bowel Diseases; Interleukin-10; Intestinal Mucosa; Mice; Mice, Knockout; Protein Isoforms; Radiation Chimera; Trinitrobenzenesulfonic Acid	2000
An investigation into the effect and mechanisms of action of nicotine in inflammatory bowel disease. Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2000, Volume: 49, Issue:7 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Humans; Inflammatory Bowel Diseases; Leukemia; Leukotriene B4; Male; Nicotine; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Peroxidase; Rats; Rats, Wistar; Sulfasalazine; Trinitrobenzenesulfonic Acid; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha	2000
Treatment with fluoride or bisphosphonates prevents bone loss associated with colitis in the rat. Calcified tissue international, 2000, Volume: 67, Issue:5 Topics: Animals; Anti-Inflammatory Agents; Colitis; Diphosphonates; Disease Models, Animal; Inflammatory Bowel Diseases; Intestine, Large; Male; Osteoporosis; Pamidronate; Rats; Rats, Wistar; Sodium Fluoride; Tibia; Trinitrobenzenesulfonic Acid	2000
Protective role of cyclooxygenase inhibitors in the adverse action of passive cigarette smoking on the initiation of experimental colitis in rats. European journal of pharmacology, 2001, Jan-05, Volume: 411, Issue:1-2 Topics: Animals; Blotting, Western; Colitis; Colon; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Gene Expression Regulation, Enzymologic; Indomethacin; Inflammation; Inflammatory Bowel Diseases; Isoenzymes; Leukotriene B4; Male; Membrane Proteins; Peroxidase; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sulfonamides; Tobacco Smoke Pollution; Trinitrobenzenesulfonic Acid	2001
Alterations in spontaneous contractions in vitro after repeated inflammation of rat distal colon. American journal of physiology. Gastrointestinal and liver physiology, 2001, Volume: 280, Issue:5 Topics: Animals; Colitis; Colon; Disease Models, Animal; Gastrointestinal Motility; Guanidines; In Vitro Techniques; Inflammation; Inflammatory Bowel Diseases; Male; Muscle Contraction; Muscle, Smooth; NADPH Dehydrogenase; Nitric Oxide Synthase; omega-N-Methylarginine; Rats; Rats, Sprague-Dawley; Tetrodotoxin; Time Factors; Trinitrobenzenesulfonic Acid	2001
Pattern of cytokine and adhesion molecule mRNA in hapten-induced relapsing colon inflammation in the rat. Inflammation, 2001, Volume: 25, Issue:1 Topics: Animals; Cell Adhesion Molecules; Chronic Disease; Colitis; Cytokines; Disease Models, Animal; Disease Progression; E-Selectin; Gene Expression Regulation; Granulocytes; Haptens; Inflammatory Bowel Diseases; Integrin beta Chains; Integrins; Intercellular Adhesion Molecule-1; Interferon-gamma; Intestinal Mucosa; Monocytes; P-Selectin; Rats; Rats, Sprague-Dawley; Recurrence; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; T-Lymphocytes; Transcription, Genetic; Trinitrobenzenesulfonic Acid; Vascular Cell Adhesion Molecule-1	2001
[The establishment of TNBS-induced experimental colitis]. Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae, 1998, Volume: 20, Issue:4 Topics: Animals; Ethanol; Haptens; Inflammatory Bowel Diseases; Intestines; Male; Peroxidase; Rats; Rats, Wistar; Superoxide Dismutase; Trinitrobenzenesulfonic Acid	1998
Changes of colonic mucosal microcirculation and histology in two colitis models: an experimental study using intravital microscopy and a new histological scoring system. Digestive diseases and sciences, 2001, Volume: 46, Issue:11 Topics: Animals; Colitis; Colon; Inflammatory Bowel Diseases; Intestinal Mucosa; Male; Microcirculation; Mitomycin; Rats; Rats, Sprague-Dawley; Time Factors; Trinitrobenzenesulfonic Acid	2001
Effects of a COX-2 preferential agent nimesulide on TNBS-induced acute inflammation in the gut. Inflammation, 2001, Volume: 25, Issue:5 Topics: Acute Disease; Animals; Aspirin; Colitis; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dexamethasone; Dinoprostone; Disease Models, Animal; Drug Evaluation, Preclinical; Indomethacin; Inflammation; Inflammatory Bowel Diseases; Isoenzymes; Male; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Sulfonamides; Trinitrobenzenesulfonic Acid	2001
Porcine ileitis model induced by TNBS-ethanol instillation. Digestive diseases and sciences, 2002, Volume: 47, Issue:4 Topics: Animals; Disease Models, Animal; Drug Combinations; Ethanol; Female; Ileitis; Inflammatory Bowel Diseases; Intestinal Mucosa; Male; Swine; Time Factors; Trinitrobenzenesulfonic Acid	2002
The in vitro anti-inflammatory effects of recombinant anti-CD25 immunotoxin on lamina propria T cells of patients with inflammatory bowel disease are not sufficient to cure experimental colitis in mice. International journal of colorectal disease, 2002, Volume: 17, Issue:2 Topics: Adult; Animals; Antibodies, Monoclonal; Apoptosis; Colitis; Female; Humans; Immunotoxins; In Vitro Techniques; Inflammation; Inflammatory Bowel Diseases; Interferon-gamma; Intestinal Mucosa; Male; Mice; Mice, Inbred BALB C; Middle Aged; Receptors, Interleukin-2; Single-Chain Antibodies; T-Lymphocytes; Trinitrobenzenesulfonic Acid	2002
Chronic intrajejunal TNBS application in TNBS-sensitized rats: a new model of chronic inflammatory bowel diseases. Agents and actions, 1992, Volume: Spec No Topics: Aminosalicylic Acids; Animals; Disease Models, Animal; Female; Immunization; Inflammatory Bowel Diseases; Intestinal Mucosa; Jejunum; Mesalamine; Rats; Rats, Sprague-Dawley; Sulfasalazine; Trinitrobenzenesulfonic Acid	1992
Protective influence of oxypurinol on the trinitrobenzene sulfonic acid(TNB) model of inflammatory bowel disease in rats. Cellular and molecular biology, 1992, Volume: 38, Issue:2 Topics: Animals; Colon; Disease Models, Animal; Free Radical Scavengers; Free Radicals; Inflammatory Bowel Diseases; Kinetics; Nucleotides; Oxypurinol; Rats; Thiobarbiturates; Trinitrobenzenesulfonic Acid; Xanthine Oxidase	1992
Relationship between arachidonic acid metabolism, myeloperoxidase activity and leukocyte infiltration in a rat model of inflammatory bowel disease. Agents and actions, 1988, Volume: 25, Issue:1-2 Topics: Animals; Arachidonic Acid; Arachidonic Acids; Colon; Female; Hydroxyeicosatetraenoic Acids; Inflammatory Bowel Diseases; Leukocytes; Peroxidase; Rats; Rats, Inbred Strains; Trinitrobenzenesulfonic Acid	1988